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A B S T R A C T
Background
Breast cancer is the most common cancer affecting women worldwide. It is a distressing diagnosis and, as a result, considerable research
has examined the psychological sequelae of being diagnosed and treated for breast cancer. Breast cancer is associated with increased
rates of depression and anxiety and reduced quality of life. As a consequence, multiple studies have explored the impact of psychological
interventions on the psychological distress experienced after a diagnosis of breast cancer.
Objectives
To assess the effects of psychological interventions on psychological morbidities, quality of life and survival among women with non-
metastatic breast cancer.
Search methods
We searched the following databases up to 16 May 2013: the Cochrane Breast Cancer Group Specialised Register, CENTRAL,
MEDLINE, EMBASE, CINAHL and PsycINFO; and reference lists of articles. We also searched the World Health Organization
International Clinical Trials Registry Platform (WHO ICTRP) search portal and ClinicalTrials.gov for ongoing trials in addition to
handsearching.
Selection criteria
Randomised controlled trials that assessed the effectiveness of psychological interventions for non-metastatic breast cancer in women.
Data collection and analysis
Two review authors independently appraised and extracted data from eligible trials. Any disagreement was resolved by discussion.
Extracted data included information about participants, methods, the intervention and outcome.
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Main results
Twenty-eight randomised controlled trials comprising 3940 participants were included. The most frequent reasons for exclusion were
non-randomised trials and the inclusion of women with metastatic disease. A wide range of interventions were evaluated, with 24 trials
investigating a cognitive behavioural therapy and four trials investigating psychotherapy compared to control. Pooled standardised
mean differences (SMD) from baseline indicated less depression (SMD -1.01, 95% confidence interval (CI) -1.83 to -0.18; P = 0.02;
7 studies, 637 participants, I2 = 95%, low quality evidence), anxiety (SMD -0.48, 95% CI -0.76 to -0.21; P = 0.0006; 8 studies, 776
participants, I2 = 64%, low quality evidence) and mood disturbance (SMD -0.28, 95% CI -0.43 to -0.13; P = 0.0003; 8 studies, 1536
participants, I2 = 47%, moderate quality evidence) for the cognitive behavioural therapy group than the control group. For quality of
life, only an individually-delivered cognitive behavioural intervention showed significantly better quality of life than the control with
an SMD of 0.65 (95% CI 0.07 to 1.23; P = 0.03; 3 studies, 141 participants, I2 = 41%, very low quality evidence). Pooled data from
two group-delivered studies showed a non-significant overall survival benefit favouring cognitive behavioural therapy compared to
control (pooled hazard ratio (HR) 0.76, 95% CI 0.25 to 2.32; P = 0.63; 530 participants, I2 = 84%, low quality evidence). Four studies
compared psychotherapy to control with one to two studies reporting on each outcome. The four studies were assessed as high risk of
bias and provided limited evidence of the efficacy of psychotherapy. Adverse events were not reported in any of the included studies.
Authors’ conclusions
A psychological intervention, namely cognitive behavioural therapy, produced favourable effects on some psychological outcomes, in
particular anxiety, depression and mood disturbance. However, the evidence for survival improvement is still lacking. These findings
are open to criticism because of the notable heterogeneity across the included studies and the shortcomings of the included studies.
P L A I N L A N G U A G E S U M M A R Y
Use of psychological interventions in women diagnosed and under treatment for non-metastatic breast cancer
Review question
We reviewed the evidence for the effect of psychological interventions on the psychological impact, quality of life and survival among
women with non-metastatic breast cancer (that is cancer that has not spread beyond the breast).
Background
Breast cancer is the most common cancer affecting women worldwide. Being a distressing diagnosis, considerable research has examined
the psychological consequences of being diagnosed and treated for breast cancer. Breast cancer diagnosis and treatment can cause
depression and anxiety and reduce quality of life. As a result, various psychological interventions have been utilised to help address the
psychological distress experienced after a diagnosis of breast cancer.
Study characteristics
The evidence was current to May 2013. An intervention could be delivered in a group setting (group intervention), as one to one
contact between a therapist and a patient (individual intervention) or in the form of couple therapy where the patient and her spouse
attends the therapy sessions (couple intervention). The control group could receive educational leaflets or have access to seminars or
relaxation classes. A comprehensive search of the literature was conducted and 28 studies comprising 3940 participants were included.
The majority (24 out of 28 studies) of interventions were based on cognitive behavioural therapy, which involves changing a person’s
thoughts and behaviour. Four studies used psychotherapy as the intervention. Generally, the methods for assessing outcomes (such as
anxiety, depression, quality of life) after the intervention and the timing of these assessments were not uniform across studies.
Key results
Women who received cognitive behavioural therapy showed important reductions in anxiety, depression and mood disturbance,
especially when it was delivered to groups of women. An improvement in quality of life was observed when women received individual
cognitive behavioural therapy compared to the control group. The effects on survival were uncertain because the results were imprecise.
The four psychotherapy studies reported limited information for each outcome. Therefore no firm conclusion could be made about
the efficacy of psychotherapy.
Adverse events were not reported in any of the included studies.
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Further research should aim to provide evidence for people to make informed decisions about whether the effects of these treatments
are sustainable after discontinuation of the therapy.
Quality of the evidence
The quality of evidence ranged from very low quality (for example for quality of life, individually delivered intervention) to moderate
quality evidence (for mood disturbance). The interventions varied between studies as did the methods and timing of outcome measures
and treatment received within the control groups.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Cognitive behavioural therapy versus control for women with non-metastatic breast cancer
Patient or population: Women with non-metastatic breast cancer
Settings: Clinics or cancer centres
Intervention: Cognitive behavioural therapy versus control
Outcomes Illustrative comparative
risks* (95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Corresponding risk
Cognitive behavioural
therapy versus control
Depression
Hospital Anxiety and De-
pression Scale (HADS)
or Beck Inventory Score
(HADS score range from
0 to 21 and Beck Inven-
tory Score range from 0
to 63)1
Follow-up: 1 to 12
months
The mean depression in
the intervention groups
was
1.01 standard deviations
lower
(1.83 to 0.18 lower)
637
(7 studies)
⊕⊕©©
low2,3,4
SMD -1.01 (95% CI -1.83
to -0.18)
Anxiety
Hospital Anxiety Scale,
STAI, Smith Anxiety Scale
Follow-up: 4 to 12 weeks
The mean change in anx-
iety in the intervention
groups was
0.48 standard deviations
lower
(0.76 to 0.21 lower)
776
(8 studies)
⊕⊕©©
low5,6,7
SMD -0.48 (95% CI -0.76
to -0.21)
Mood disturbance
Profile of mood state
(higher score indicates
more mood disturbance,
score range from 0 to
200)
Follow-up: 1 to 12
months
The mean mood distur-
bance in the intervention
groups was
0.28 standard deviations
lower
(0.43 to 0.13 lower)
1536
(8 studies)
⊕⊕⊕©
moderate8,9
SMD -0.28 (95% CI -0.43
to -0.13)
Quality of life: Group-de-
livered intervention
Several tools were used
eg EORTC, FACT B, Med-
ical outcomes, QoL Can-
cer Survivor
Follow-up: 1 to 12
months
The mean quality of life:
group-delivered interven-
tion in the intervention
groups was
0.21 standard deviations
higher
(0.03 lower to 0.46
higher)
578
(6 studies)
⊕⊕©©
low10,11
SMD 0.21 (95% CI -0.03
to 0.46)
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Quality of life: Individ-
ually-delivered interven-
tion
Linear Analog Self As-
sessment Scale, FACT,
EORTC
Follow-up: 6 weeks to 12
months
The mean quality of life:
individually-delivered in-
tervention in the interven-
tion groups was
0.65 standard deviations
higher
(0.07 to 1.23 higher)
141
(3 studies)
⊕©©©
very low12,13,14
SMD 0.65 (95% CI 0.07
to 1.23)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
1 A higher score on either tool indicated higher depression
2 No allocation concealment in two studies
3 Two different scales were used to measure the outcome
4 Unexplained heterogeneity was introduced by one study
5 In two studies, allocation concealment was not done; in the remaining studies it was not reported
6 Three different tools and several subscales were used to measure the outcome
7 In one study, the high percentage of losses to follow up could not be explained
8 Three or more domains of risk of bias including allocation concealment were judged as having an unclear risk of bias. In one study,
allocation concealment was not done
9 Different forms of the POMS tool was used to measure mood disturbance (ie total score versus sub-scale score)
10 In three studies, one or more of the risk of bias domains including allocation concealment was judged as having an unclear risk of bias
11 Four different tools were used to measure QoL
12 In the three included studies, at least four risk of bias domains including allocation concealment were judged as having an unclear risk
of bias
13 Three different tools were used to measure QoL in this analysis
14 The sample size was too small in one study and there was an unexplained 50% loss at follow-up in the control group in another study
B A C K G R O U N D
Description of the condition
Breast cancer is the most common cancer in women of all ages.
About 1.3 million women will be diagnosed with breast cancer
every year worldwide and about 465,000 will die from the dis-
ease making it the third leading cause of death in women, after
heart disease and lung cancer (ACS 2009). Improved prevention
and detection methods, as well as advances in medical treatment,
have resulted in a trend toward increasing numbers of cancer sur-
vivors (ACS 2009). Survival gains achieved in breast cancer have
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produced a growing acceptance of breast cancer as a long-term
illness and have led to a greater emphasis on rehabilitation and
subsequently the quality of life (QoL) of these women (Reynolds
2000). Despite the growing recognition of the need to address
the psychological requirements of patients with cancer, the cur-
rent practice has lagged in targeting the psychological elements of
living with cancer resulting in disparity in comprehensive cancer
care (Greer 2013).
Breast cancer is still a distressing diagnosis and, as a result, consid-
erable research has examined the psychological sequelae of being
diagnosed and treated for breast cancer. In line with the increasing
adoption of a bio-psychosocial model of health care, one focus of
interest has been to determine whether a diagnosis of breast cancer
is associated with specific psychological disorders, and what course
these take in patients (Fann 2008; Okamura 2005; Reich 2008).
Psychological morbidities (the incidence or prevalence of psycho-
logical disorders) such as anxiety, depression, stress, distress, diffi-
culty in adjustment and decreased social interactions (Vos 2004)
are common responses to the diagnosis and treatment of breast
cancer. Such responses may arise from pain (Reddick 2005), fear
of recurrence, treatment side-effects, life stresses (Low 2006) and
lymphoedema (McWayne 2005). Many women consider chemo-
therapy as the most distressing aspect of treatment as it is usually
associated with unpleasant symptoms such as nausea, emesis, fa-
tigue and alopecia (Boehmke 2005; Partridge 2001). The debili-
tating effects are more profound in younger women who also ex-
perience the sudden onset of early menopause with the attendant
symptoms of hot flashes, decreased sexual desire and vaginal dry-
ness (Baucom 2005; Partridge 2004). Notably, younger women
may have specific fertility needs and concerns (Peate 2009).
The considerable data available in relation to psychological con-
ditions associated with breast cancer suggest that depression and
anxiety are the most commonly studied mood disorders (Fann
2008). Rates of major depression or anxiety in breast cancer pa-
tients have been estimated to range from 20% to 30% in the initial
six months following breast cancer diagnosis in women with early
stage breast cancer (Akechi 2001; Fallowfield 1990). However, a
recent study suggests that the number of patients approaching the
threshold for depressive and anxiety disorders (including border-
line cases) is close to 50% in the first year after diagnosis, dropping
rapidly in the second year to 25% and following a further gradual
sustained decrease over the five-year study period to 15% in the
fifth year (Burgess 2005). On the other hand, results from the
UKStandardisation of Radiation TherapyTrials (START) showed
that about one third (35%) of women reported anxiety or depres-
sion, or both, which did not significantly change over five years of
follow up (Hopwood 2010).
A review of 37 studies on the epidemiology of major depression
in women with breast cancer suggested a rate of 10% to 25%
(Fann 2008). In a large cohort of 4496 patients with cancer, the
prevalence of depression in those with breast cancer was estimated
to be around 52% (Zabora 2001). This wide variation in rates
of psychological disorders may be attributed to methodological
differences across studies, different characteristics of the groups
studied, heterogeneous tumour stage and the stage at which assess-
ment took place in relation to diagnosis or treatment. Moreover,
the use of different diagnostic criteria for depression and anxiety
may have contributed to the different rates reported in the above
studies (Chochinov 1994). Predictors of psychological morbid-
ity following breast cancer diagnosis and treatment were primar-
ily related to the patient (namely younger age, previous psycho-
logical problems and a lack of social support) rather than to the
disease or treatment (Burgess 2005). Socio-economically deprived
patients were also at risk of depression at three to four months after
surgery (Christensen 2009). Adjuvant chemotherapy was found
to increase the risk of depression or anxiety, or both, during but
not after treatment (Burgess 2005). These side-effects varied de-
pending on the specific agents used in the adjuvant regimen as
well as the dose and duration of treatment (Boehmke 2005).
One quarter of the women studied maintained clinically signifi-
cant levels of distress over a 12-month period (Millar 2005). Dis-
tress emerged or intensified when women expected symptoms to
disappear but they continued to persist (Rosedale 2010). How-
ever, themost intense or frequently occurring symptom is not nec-
essarily the most distressing to patients (Bárez 2009; Henselmans
2009). Most research has focused on the identification of predic-
tive variables related to higher levels of symptom distress, such as
age (Baider 2003), coping style (Ben-Zur 2001), baseline anxi-
ety and depression, and fear of recurrence (Lebel 2009). When
compared to a cohort of matched women free of disease, women
with breast cancer exhibited significantly higher levels of distress
and different coping styles from their counterparts in the control
group (Amir 2002).
In addition to specific psychological disorders such as anxiety and
depression, over the last two decades QoL outcomes have been
increasingly used as an outcome variable in breast cancer research
(Hewitt 2004). These studies have collectively examined QoL
outcomes for women diagnosed at different ages, various stages
of the disease, and at different time intervals between diagnosis
and treatment (Ganz 2002). Most but not all data suggest that a
younger age and shorter duration of time from diagnosis are asso-
ciated with poorer QoL (Ganz 2002; Mols 2005). Social support
from family members and friends helps to decrease the negative
effects of symptoms on QoL (Ashing-Giwa 2009; Kulik 2005;
Manning-Walsh 2005) and improve women’s adjustments and
ability to cope (Bloom 1982). Social deprivation was also related
to poor breast cancer prognosis (Vona-Davis 2009).
In addition to the impact on psychological disorders and QoL, it
has been suggested that psychological distress following breast can-
cer diagnosis and treatment may adversely affect survival (Spiegel
1989), although this latter outcome is controversial (Smedslund
2004). Moreover, fighting spirit was linked to recurrence-free sur-
vival in one of the pioneering studies in this field (Greer 1979).
As a consequence of the effects of breast cancer on depression,
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anxiety and QoL, various psychological interventions have been
utilised to help address the psychological distress experienced after
a diagnosis of breast cancer. This systematic review seeks to assess
the effectiveness of those therapies that have been subjected to
controlled trials thus far.
Description of the intervention
Psychological intervention includes a wide range of therapeutic
techniques and is poorly defined in the literature.
Cognitive behavioural therapy (CBT) is a psychotherapeutic ap-
proach that aims to solve problems concerning dysfunctional cog-
nition, emotions and behaviours through a goal-oriented system-
atic procedure. CBT includes a variety of approaches and thera-
peutic systems; some of the most well known include cognitive
therapy, rational emotive behaviour therapy and multimodal ther-
apy. CBT focuses on changing specific thoughts or behaviours or
on learning specific coping skills (Hopko 2008), such as progres-
sivemuscle relaxation training,meditation, hypnotherapy, system-
atic desensitisation, biofeedback, behaviour modification or rein-
forcement and cognitive therapy. In the past decade, research has
supported mindfulness-based therapies such as meditation for a
number of medical and psychological conditions accompanying
breast cancer diagnosis and treatment (Carlson 2003; Lengacher
2009). In recent years, CBT therapists have witnessed a shift to-
wards focused therapies such as acceptance and commitment ther-
apy (ACT) (Dahl 2004).
Psychotherapy, or personal counselling with a psychotherapist,
is an intentional interpersonal relationship used by trained psy-
chotherapists to aid a client or patient in problems of living. It in-
cludes non-directive, psychodynamic, existential, supportive, gen-
eral or crisis intervention; no specific behavioural or coping skills
are taught (Barsevick 2002).
Group psychotherapy, or group therapy, is a form of psychother-
apy in which one or more therapists treat a small group of clients
(Montgomery 2002). The term refers to any form of psychother-
apy when delivered to a group, including CBT, interpersonal ther-
apy and psychodynamic group therapies; the group process ex-
plicitly using mechanisms of change by developing, exploring and
examining interpersonal relationships within the group.
A psycho-educational intervention is the education offered to peo-
ple who live with a psychological disturbance. Frequently, psycho-
educational training involves patient training courses in the con-
text of treating a physical illness (Bäuml 2008). Family members
are also included in the education. Patients and their relatives are
empowered to understand and accept the illness and cope with it
in a successful manner (Bäuml 2008). The goal is for the patient to
understand and deal with the presenting illness. Also, the patients’
own strengths, resources and coping skills are reinforced in order
to avoid relapse and for them to contribute to their own health and
wellness on a long-term basis. The theory considers that the better
knowledge the patient has of her illness, the better the patient can
live with her condition.
How the intervention might work
The purpose of psychological support programmes in breast can-
cer is to promote awareness and education, provide emotional
support, and assist women with problem solving so that they can
go through the processes and cope better with cancer (Sandgren
2000). It has been suggested that understanding the uncertainty
that is experienced plays a key role in positively influencing future
behaviours (Montgomery 2010). For example, CBT was the most
frequently used approach in studying the effect of psychological
intervention in cancer patients (Moyer 2009; Redd 2001) and has
been shown to be a valuable tool in relieving distress in various
cancer populations (Mundy 2003), particularly amongst breast
cancer patients (Tatrow 2006).
Why it is important to do this review
There is an accumulating amount of research concerned with the
effects of psychological interventions on QoL and psychological
morbidity in women with non-metastatic or early stage breast can-
cer. Yet the strength of this relationship is unknown because stud-
ies have not been combined into a systematic review. Several items
pertaining to psychological interventions in early stage breast can-
cer remain unresolved; for instance, which interventions work the
best, for which patients, and other items related to the therapy (for
example duration, dose, type and optimal time to start therapy).
Hence, the true effect of psychological interventions on the QoL
of women with non-metastatic breast cancer remains unclear. We
conducted this systematic review to explore the uncertainty arising
from conflicting results in a number of studies in this area.
Previous reviews of psychological intervention were conducted on
women with metastatic breast cancer, which limited the appli-
cability of the review to the larger group of women with non-
metastatic breast cancer (Edwards 2008; Mustafa 2013). Indeed,
one might question whether women with non-metastatic breast
cancer have different outcomes to those women with metastatic
breast cancer, especially as early detection and treatment continue
to improve and patients continue to live longer.
O B J E C T I V E S
To assess the effects of psychological interventions on psycho-
logical morbidities, QoL and survival among women with non-
metastatic breast cancer.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials which compare any form of psy-
chological or behavioural intervention with a placebo, waiting list
control or an alternative form of psychological intervention.
Types of participants
Women with a histologically confirmed diagnosis of breast car-
cinoma of an early non-metastatic stage (Grade I-III) as defined
by the American Joint Committee on Cancer (AJCC) TNM (tu-
mour, lymph nodes, metastasis) staging system (American Joint
Committee on Cancer 2009).
The following studies were excluded:
• studies including women with distant metastasis (Grade
IV) unless there were subgroup analyses;
• studies including patients with other types of cancer unless
there were subgroup analyses of breast cancer groups;
• studies about psychological intervention in caregivers of
women with breast cancer as they represent a different entity.
Types of interventions
A range of psychological interventions to prevent or treat psycho-
logical distress were eligible for inclusion:
• cognitive behavioural techniques;
• psychotherapy or counselling; and
• psycho-educational interventions.
We compared these interventions to an inactive control interven-
tion; that is placebo, standard care or waiting list control: ’a group
that is assigned to a waiting list to receive an intervention after
the active treatment group does’, or with an active control inter-
vention (for example another form of psychological intervention).
Studies with multi-interventions were excluded unless data were
extractable.
Types of outcome measures
Primary outcomes
• Depression: depression score measured using any validated
disease specific tool at the end of the study
• Anxiety: anxiety score measured using any validated disease
specific tool at the end of the study
• Stress: stress score measured using any validated disease
specific tool at the end of the study
• Mood disturbance: mood disturbance score measured using
any validated disease specific tool at the end of the study
Secondary outcomes
• Quality of life (QoL): QoL score measured using any
validated questionnaire at the end of the study
• Coping: coping score measured using any validated disease
specific tool at the end of the study
• Adjustment: adjustment score measured using any validated
disease specific tool at the end of the study
• Survival: all cause patient survival at the latest study time
point
Search methods for identification of studies
See: Breast Cancer Group methods used in reviews
There were no language limits. Articles in all languages were
searched and relevant abstracts were translated.
Electronic searches
We searched the following databases.
1. The Cochrane Breast Cancer Group’s (CBCG) Specialised
Register maintained by the Cochrane Breast Cancer Group was
searched on the 16 May 2013. Details of the search strategies
used by the CBCG for the identification of studies and the
procedure used to code references are outlined in their module (
http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/
BREASTCA/frame.html). Trials with the key words
’psychological intervention’, ’early breast cancer’, ’cognitive
behavioural technique’, ’cognitive behavioural therapy’,
’psychotherapy’, ’psycho-educational therapy’,
’psychotherapeutic’, ’CBT’ and ’acceptance and commitment
therapy’ were extracted for consideration.
2. The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2013, Issue 3). See
Appendix 1.
3. MEDLINE (via OvidSP) (July 2008 to 16 May 2013). See
Appendix 2.
4. EMBASE (via Embase.com) (2008 to 16 May 2013). See
Appendix 3.
5. PsycINFO (via OvidSP) (1960 to 16 May 2013). See
Appendix 4.
6. CINAHL (via EBSCO) (1982 to 16 May 2013). See
Appendix 5.
7. The World Health Organization (WHO) International
Clinical Trials Registry Platform (ICTRP) search portal (http://
apps.who.int/trialsearch/Default.aspx) for all prospectively
registered and ongoing trials (16 May 2013). See Appendix 6.
8. Clinicaltrials.gov (http://clinicaltrials.gov/ct2/search) (16
May 2013). See Appendix 7.
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9. Other databases: CancerLit, PsyLit, Iranmedex, Indmed
(July 2008 to May 2013). See Appendix 8; Appendix 9;
Appendix 10; Appendix 11.
Searches were initially undertaken using key words then followed
by searches of related articles until previously selected papers were
obtained. Key words used were: breast cancer, breast neoplasm,
quality of life, well-being, depression, anxiety, stress, distress, ad-
justment, coping, mental health, health-related quality of life, psy-
chological intervention, psychological morbidity, psychiatric mor-
bidity, cognitive behavioral therapy, group psychotherapy, relax-
ation, supportive therapy, visual imagery and psychosocial inter-
vention.
Searching other resources
Searches also included the following.
(a) Bibliography searching.The bibliographies of all included stud-
ies and review papers were searched in order to identify other po-
tentially suitable studies. Articles cited by relevant studies were re-
viewed. Language restrictions were not imposed. Full translations
of all non-English language papers were conducted using local re-
sources.
(b) Unpublished literature. Experts in this field were contacted.
Letters were sent to all authors of included studies requesting in-
formation on unpublished data or ongoing studies.
(c) Handsearching of journals. A list of journals currently be-
ing handsearched by The Cochrane Collaboration is available at
the US Cochrane Center Handsearch master list page (http://
apps1.jhsph.edu/cochrane/masterlist.asp).
Data collection and analysis
Selection of studies
Two authors (GJ and DW) independently assessed the titles and
abstracts of each identified trial for inclusion into the review. After
the initial assessment, we obtained full versions of all potentially
relevant articles. A third author (AH) was approached to resolve
any discrepancies regarding eligibility.
If the results of a randomised controlled trial (RCT) were unpub-
lished but available, and three authors (GJ, DW and AH) were
satisfied with the quality of the data, data were included (where
possible) and disclosed in the discussion section. Trials were in-
cluded if randomisation and patient preference allocation arms
analysis were performed. If these analyses were not completed, the
trials were dealt with separately because of the risk of allocation
bias.
Additional data or information were sought from the principal
investigator of the trial concerned, where necessary.
Data extraction and management
Data from all relevant studies were extracted and entered into
the ’Characteristics of included studies’ table in RevMan 5.2 (
RevMan). All studies were appraised independently by two review
authors (GJ, DW). Any disagreement was resolved by discussion.
Extracted data included the following.
(a) Participants: country of origin, sample size, setting, diagnostic
criteria, age, ethnicity, date of study and data on baseline psycho-
logical morbidity for assessment of effect modifiers.
(b) Methods: study design, methods of allocation, allocation se-
quence concealment, blinding, exclusion of participants after ran-
domisation, proportion and reasons for loss at follow up.
(c) Interventions: type, dose, length and frequency of intervention
(for each intervention and comparison group).
(d) Outcomes: primary and secondary outcomes using validated
instruments were extracted.
If mentioned, sources of funding were recorded in the ’Character-
istics of included studies’.
Assessment of risk of bias in included studies
Two review authors (GJ and DW) graded and assessed each se-
lected trial using a simple contingency form, addressing the seven
specific domains discussed in Chapter 8 of theCochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011). The evalu-
ations given by all authors were compared and any inconsistencies
and disagreements were resolved by discussion. Each domain was
assigned a judgement related to the risk of bias in that domain.
Judgements used were: ’low risk of bias’, ‘high risk of bias’, and
’unclear’, which indicated unclear or an unknown risk of bias. The
domains were:
1. sequence generation;
2. allocation concealment;
3. blinding of participants and personnel;
4. blinding of outcome assessors;
5. incomplete outcome data;
6. selective outcome reporting; and
7. other sources of bias.
Assessment of these domains for each trial are reported in the Risk
of bias in included studies. We also categorised and reported the
overall risk of bias of each of the included studies according to the
following:
• low risk of bias (bias is unlikely to seriously alter the results)
if all criteria were met;
• unclear risk of bias (bias raises some doubt about the
results) if one or more criteria were assessed as unclear;
• high risk of bias (bias seriously weakens confidence in the
results) if one or more criteria were not met.
Measures of treatment effect
The data could have been presented as continuous (for example
changes in depression scales), dichotomous (for example either
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depressed or not depressed), ordinal (for example categories on
a QoL scale such as mild, moderate and severe) or time-to-event
data (for example survival data). Decisions regarding if and how to
combine these outcomes were made depending on how the data
were collected by each trial. These decisionswere guided by section
9.2 ’Types of data and effect measures’ in the Cochrane Handbook
for Systematic Reviews of Interventions 5.0.0 (Higgins 2011).
For continuous data, we presented the change from baseline as the
standardised mean difference (SMD) due to the same outcome
being measured in a variety of ways using different scales. For
future updates, the mean and standard deviation will be reported
if possible (that is when the outcome measurements in all studies
are made on the same scale).
Dichotomous data were not used in this version of the review. In
future updates of the review, if presented with dichotomous data
and the authors have specified a cut-off point for determining clin-
ical effectiveness, we will use this where appropriate. Otherwise,
cut-off points on rating scales will be identified and participants
will be divided on the basis of whether they were clinically im-
proved or not. For dichotomous outcomes in future updates, a
Mantel-Haenszel odds ratio with its associated 95% confidence
interval (CI) will be estimated.
In the case of time-to-event data (overall all-cause survival and
progression-free survival), intervention effects were expressed as
hazard ratios.
All measures of effect included 95% CIs, P values, and for pooled
measures the I2statistic.
Unit of analysis issues
No studies were identified that experienced unit of analysis issues
and it is unlikely that studies of this type will be identified in future
updates. If these complications are found in updates, guidance
will be taken from Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011) and changes between the protocol
and the updated review will be highlighted.
Dealing with missing data
If data were missing from trials less than 10 years old, we tried
wherever possible to contact the investigators or sponsors of these
studies. We re-analysed data according to the intention-to-treat
(ITT) principle whenever possible. If authors had conducted a per
protocol analysis instead of an ITT analysis these results were in-
cluded.Where baseline and follow-up data only were summarised,
the change from baseline scores have been estimated assuming
a common correlation of structure of 0.8 (section 16.1.3.2 in
the Cochrane Handbook for Systematic Reviews of Interventions)
(Higgins 2011). In cases where variability data were summarised
at baseline but not at follow up, the variance was assumed to have
remained unchanged. In cases where medians were presented with
ranges, the mean was estimated by the median and the variance
by using the range and the number of observations (Hozo 2005).
Assessment of heterogeneity
To check for statistical heterogeneity between studies, both the I
2 statistic and Chi2 test of heterogeneity as well as visual inspec-
tion of the forest plots were used. The graphical representation of
the data was inspected; if CIs for the results of individual studies
have poor overlap it generally indicates the presence of statistical
heterogeneity. In addition, the Chi2 test was performed to check
for differences between the results of each included trial. A P value
of 0.10, rather than the conventional level of 0.05, was used to
determine the statistical significance. A low P value provides evi-
dence of heterogeneity of intervention effects Higgins 2011. The
I2 statistic was used to quantify inconsistency across studies.
We assessed clinical heterogeneity by examining the characteristics
of the studies, the similarity between the types of participants and
the interventions. We reported heterogeneity as important if it
was at least moderate to substantial with the I2 statistic greater
than 60% (Higgins 2011). If this could be explained by clinical
reasoning and a coherent argument could be made for combining
the studies, these were entered into a meta-analysis. In cases where
the heterogeneity could not be adequately explained, the data were
not pooled.
The clinical diversity between the studies included in this review as
well as the limited number of studies that could be combined for
each intervention allowed us to make assessments of heterogeneity
between the studies for only one of the comparisons.
Assessment of reporting biases
We followed the recommendations on testing for funnel plot asym-
metry as described in section 10.4.3.1 of the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011). In future
updates of this review, tests for funnel plot asymmetry will be used
only when there are at least 10 studies included in the meta-anal-
ysis. When there are fewer than 10 studies the power of the tests
is too low to distinguish chance from real asymmetry. We will vi-
sually inspect the funnel plots and discuss reasons for funnel plot
asymmetry in the discussion. We will follow the proposed tests for
funnel plot asymmetry as outlined in table 10.4.b in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Data synthesis
One review author (BC) analysed the data inRevMan and reported
them in accordance with the advice in Chapter 9 of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Where data could be pooled, for continuous outcomes an inverse
variance approach was taken to meta-analysis fitting a random-ef-
fects model. The degree of heterogeneity was summarised with the
I2 statistic. The time-to-event data were pooled using the generic
inverse variance method and the hazard ratio presented.
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Subgroup analysis and investigation of heterogeneity
Subgroup analyses were conducted to test the interaction between
the variables determined a priori and the overall treatment effect.
In this review, two of the six pre-specified subgroup analyses were
possible using the available data: (1) different doses of psycholog-
ical intervention (≤ 20 hours versus > 20 hours) and (2) group
versus individually-delivered intervention.
If possible, in future review updates we will consider conducting
the following.
• Age of participants (≤ 50 years versus > 50 years).
• Dose of psychological intervention (≤ 20 hours versus > 20
hours).
• Duration of psychological intervention (≤ 8 weeks versus >
8 weeks).
• Type of psychological intervention (individual versus
group).
• Type of therapy received (total mastectomy versus
conservative surgery, chemotherapy, radiotherapy and hormonal
therapy).
• Time point at which the outcome (ie with placebo too) was
assessed (≤ 4 months after surgery versus > 4 months).
Sensitivity analysis
The impact of the methodological quality on overall effect size
was determined by sensitivity analyses. Sensitivity analyses were
conducted to assess the robustness of the review results by carrying
out the following, where possible:
• where heterogeneity existed, the removal of those studies
that were considered to be estimating a different effect;
• removal of studies with high risk of bias and including
studies with low risk of bias only.
R E S U L T S
Description of studies
See: Figure 1; Characteristics of included studies table and
Characteristics of excluded studies table.
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Figure 1. Figure 1. Study flow diagram.
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Results of the search
We retrieved 2854 references to studies. After examination of the
titles and abstracts of these references, we deleted duplicates and
eliminated all of those which did not match our inclusion crite-
ria and those which were clearly ineligible. We obtained full text
copies of the remaining 150 potentially eligible studies for fur-
ther evaluation. Seven of these needed translation (four in Span-
ish (Gabaldon 1993; Greer 1992; Narváez 2008; Paez 2007), two
Chinese (Feng 1998; Yan 2001) and one French (Cayrou 2005)).
Five studies were translated prior to assessment of eligibility, one
was excludedbased on the abstract alone (Gabaldon 1993) andone
is awaiting classification (see Characteristics of studies awaiting
classification table).
Twenty-eight studies proved to be eligible for inclusion in this
review. One hundred and fourteen studies were excluded and
reasons for the exclusion of 49 key studies are provided in the
Characteristics of excluded studies table. For further details see the
’Study flow diagram’ (Figure 1).
Included studies
We included 28 randomised controlled clinical trials comprising
3940 participants. The studies were very heterogenous in the in-
terventions studied, the reporting of outcomes and the point at
which the outcome was measured. In order not to replicate par-
ticipants and findings, we combined six parent trials with their
matching substudies because the same participants were used but
the authors reported different outcomes in different published ver-
sions of the study. Andersen 2004 had an additional two stud-
ies (Andersen 2007; Andersen 2008); Antoni 2006 had two ad-
ditional studies (Antoni 2006B; Antoni 2009); Graves 2003 had
one additional Doctor of Philosophy (PhD) publication (Graves
2001); Kissane 2003 had one more publication (Kissane 2004);
Mishel 2005 had one additional publication (Gil 2006); and Vos
2004 had one additional publication (Vos 2007).
Characteristics of the trial setting and methods
Only randomised controlled trials were included. Of the studies
that were included, 15 were conducted in the US, 6 in Europe, 1
in Japan, 2 in Australia, 2 in Canada, 1 in Israel and 1 in Brazil. All
but two trials (Marchioro 1996;Richardson 1997)were conducted
in 2000 or beyond. The duration of the studies was between 3
weeks and 12 months. Most studies had two groups (control and
intervention), whereas three studies compared three different arms
(Cohen 2007; Richardson 1997; Vos 2004).
Characteristics of the participants
The number of participants included in the individual studies var-
ied widely from 14 to 575 participants. The age of the partici-
pants ranged from 18 to 80 years, with the most common lower
and upper limits being 18 and 65 years, respectively. All of the
women had been diagnosed with early stage breast cancer with no
metastases. Three studies (Badger 2007; Baucom 2009; Manne
2007) included women with their partners, whereas all other stud-
ies included the women only. The overall sample was generally
skewed towards Caucasians. In five studies participants were un-
dergoing adjuvant treatment (Badger 2007; Classen 2008; Cohen
2007;Nunes 2007; Yates 2005) and in five studies theywere await-
ing chemotherapy (Andersen 2004; Antoni 2001; Antoni 2006;
Garssen 2013; Marchioro 1996). In the remaining studies partic-
ipants had completed adjuvant therapy.
Characteristics of the interventions
A wide range of interventions were evaluated. The majority (24
out of the 28 trials) of interventions were based on cognitive be-
havioural theory. Most therapeutic interventions were delivered
face-to-face and only three were via the telephone (Badger 2007;
Marcus 2010; Mishel 2005). In some studies, mixed approaches
were used (face-to-face and telephone calls or individual coun-
selling) (Fillion 2008; Loprinzi 2011; Yates 2005). Three studies
delivered the intervention to couples as opposed to women only
(Badger 2007; Baucom 2009; Manne 2007). Twenty of the inter-
ventions were delivered in groups, including one couple interven-
tion (Manne 2007); and seven were delivered individually, includ-
ing two couple studies (Badger 2007; Baucom 2009). The mean
± SD duration of the intervention was 14 ± 9.65 hours with a me-
dian of 12 (maximum 39 hours and minimum 1 hour). Only one
study did not specify the duration of the intervention (Marchioro
1996). Most intervention sessions were delivered on a weekly ba-
sis.
The psychological interventions in the studies can be categorised
into the following.
1. Cognitive behavioural interventions: cognitive, cognitive
behavioural, and behavioural methods focused on changing
specific thoughts or behaviours or on learning specific coping
skills. Procedures coded here included progressive muscle
relaxation training, meditation, systematic desensitization,
biofeedback, and behaviour modification or reinforcement
(Andersen 2004; Antoni 2001; Antoni 2006; Baucom 2009;
Boesen 2011; Cohen 2007; Dolbeault 2009; Fillion 2008;
Ferguson 2012; Fukui 2000; Garssen 2013; Graves 2003;
Henderson 2012; Kissane 2003; Loprinzi 2011; Manne 2007;
Marchioro 1996; Mishel 2005; Narváez 2008; Nunes 2007;
Richardson 1997; Simpson 2001; Taylor 2003; Yates 2005).
2. Psychotherapy counselling: non-cognitive and non-
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behavioural verbal psychotherapy and counselling including
psychodynamic, existential, supportive or general counselling,
and crisis intervention (Badger 2007; Classen 2008; Marcus
2010; Vos 2004).
3. Informational and psycho-educational: most of the trials
included an element of education in the protocol to reinforce the
existing therapy. No studies used this type of intervention solely;
it was an add on to the existing psychological treatment.
Characteristics of the outcome measures
In general, the methods of measurement and the timing of the
assessments were not uniform across studies. Even when the same
tool was used, in some studies only some subscales or domainswere
used. In other instances the short formof the original questionnaire
was used, which further increased the heterogeneity in the data.
Depression was measured by several tools such as: the Beck De-
pression Inventory (BDI), the depression subscale of the Hospital
Anxiety and Depression Scale (HADS), and the Center for Epi-
demiological Studies-Depression Scale (CES-D).
Anxiety was measured using the State Trait Anxiety Inventory
(STAI), the Beck Anxiety Inventory (BAI), the anxiety subscale of
the HADS, the Hamilton Rating Scale for Anxiety (HAM-A) and
Smith Anxiety Scale.
Mood disturbance was mostly measured using the Profile ofMood
States (POMS) and one study used the Affect Balance Scale (ABS)
(Kissane 2003), which is composed of four positive and four neg-
ative subscales. The POMS has six subscales (anxiety, depression,
vigour, anger, fatigue and confusion) and a global score. The Total
Mood Disturbance Score (TMDS) is the sum of five scales (anx-
iety, depression, anger, fatigue and confusion) minus the score of
the vigour scale. In some studies not all subscales were used, for ex-
ample in Fillion 2008 only anxiety and depression subscales were
used; in Antoni 2001 anxiety, depression and anger were used;
however in Vos 2004 all five subscales were used. In other studies
the short form was used (Mishel 2005; Richardson 1997).
Stress and distress were used interchangeably and were measured
using the Impact of Events Scale (IES), perceived stress scale,
Brief Symptom Inventory (BSI), and theMental Health Inventory
(MHI).
Coping and adjustment were measured using the Mental Adjust-
ment to Cancer (MAC) scale, the Cancer Behavior Inventory
(CBI), the 16-PF personality questionnaire Form A, the Index In-
trojectQuestionnaire, theDealingwith Illness Inventory, theCop-
ing Strategies Questionnaire (CSQ), the Ways of Coping Ques-
tionnaire (WCQ) and the Utrecht Coping List (UCL).
Quality of life outcomes were reported in nine trials and were
measured using the EORTCC-30 and the QLQ-BR23, the Func-
tional Assessment of Cancer Therapy-Breast (FACT-B) measure,
the Fu (LASA) and Quality of life cancer survivors (QoL CS),
Functional Living Index Cancer (FLIC), the Quality of Life In-
dex (QLI), theCancer Rehabilitation and Evaluation System short
form (CARES-SF) and the Linear Analog Self Assessment Scale.
The EORTC score has been reported as a raw score or as a
transformation score. To increase comparability the raw score was
converted to the transformation score using the formula in the
EORTC scoring manual.
All-cause survival was reported in three studies only (Andersen
2008; Boesen 2011; Kissane 2004) and was measured as time from
randomisation to death at the end of the follow up period.
When two scales were used to measure the same outcome, the one
which was used mostly by other studies was chosen for consistency
of results and to increase comparability. Tools can consist of many
subscales or domains. Only the total score was included in the
meta-analysis.
Clinical diversity of the interventions
This is a pragmatic review and we have aimed to combine similar
interventions where possible. Whilst we acknowledge the differ-
ences between interventions across studies, we are interested in
investigating the generic type of intervention, for example CBT,
control or psychotherapy. The composition of the standard care
intervention (listed here as control) is dependent on the location
and context of the study. In some studies the control group re-
ceived educational leaflets, whereas in others the control included
access to seminars. In one study the control group had access to
relaxation classes (Kissane 2003).
Excluded studies
We reported the reasons for exclusion for some of excluded studies
in the ’Characteristics of excluded studies’ table. Themost frequent
reasons for exclusion were non-randomised trials and inclusion of
women with metastatic disease.
Risk of bias in included studies
We assessed the risk of bias for each included study and reported
the judgements for the individual risk of bias domains in the ’Risk
of bias’ table. We have also presented these in the ’Risk of bias’
summary in Figure 2. In addition, an overall risk of bias was de-
termined for each study and nine were categorised as high risk of
bias because one or more risk domains received a judgement of
high risk (Classen 2008; Cohen 2007; Fukui 2000; Graves 2003;
Kissane 2003; Loprinzi 2011; Narváez 2008; Richardson 1997;
Simpson 2001). The remaining 19 studies were rated as unclear
risk of bias because one or more criteria were assessed as unclear.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Some studies in this review did not provide sufficient details to
enable accurate judgements to be made. We contacted 25 authors
and were able to amend the judgements for a number of the risk
domains after receiving a reply from eight trial investigators. How-
ever, if the authors mentioned in the e-mail communication that
blinding or concealment was used without clarifying the method
that was used for randomisation or allocation concealment the
judgement remained as unclear.
Allocation
Random sequence generation
The description of the method used in random allocation was
stated clearly in 12 studies (Andersen 2004; Badger 2007; Baucom
2009; Boesen 2011; Classen 2008; Ferguson 2012; Fillion 2008;
Fukui 2000; Kissane 2003; Loprinzi 2011; Mishel 2005; Yates
2005). In Cohen 2007 a systematic order was used to allocate
women, which was judged as inadequate. In the remaining studies
the information obtained about random allocation was not suffi-
cient to permit a clear judgement.
Allocation concealment
Four studies were open labelled (Classen 2008; Cohen 2007;
Narváez 2008; Kissane 2003) and were judged as high risk of
bias. Inadequate reporting did not permit a clear judgement to be
made for this domain in 19 studies, while sufficient information
was obtained regarding allocation concealment in the remaining
5 trials (Andersen 2004; Badger 2007; Boesen 2011; Dolbeault
2009; Fillion 2008).
Blinding
Blinding of participants and personnel
Blinding of participants and personnel was not stated in 26 in-
cluded studies. Two studies (Fukui 2000; Simpson 2001) clearly
mentioned that it was not possible to blind participants or investi-
gators to the intervention considering its nature. This was judged
as unclear risk of bias because the effect of the lack of blinding on
the outcome for this type of intervention is unclear.
Blinding of outcome assessors
Blinding of outcome assessors was achieved in five studies (Antoni
2001; Antoni 2006; Badger 2007; Cohen 2007; Ferguson 2012).
In three studies it was not done (Classen 2008; Narváez 2008;
Richardson 1997) and in the remaining studies the available infor-
mation was insufficient to allow a clear judgement of this domain.
Incomplete outcome data
In seven studies incomplete outcome data appeared to have been
adequately addressed (Andersen 2004; Antoni 2006; Henderson
2012; Kissane 2003;Manne 2007; Richardson 1997; Yates 2005).
The incomplete data were reasonably well-balanced across inter-
vention groups, with intention-to-treat analyses reported. How-
ever, the high dropout rate and subsequent per protocol analysis
of the data in two studies resulted in a judgement of high risk of
bias for this domain (Graves 2003; Loprinzi 2011). In the remain-
ing 19 studies, the number of dropouts was balanced between the
groups. However, the percentage of dropouts (less than 28%) and
subsequent per protocol analysis posed an unclear risk of bias.
Selective reporting
In Classen 2008 some outcomes were not reported and in Taylor
2003 only 12-month outcomes were reported because the in-
termediate assessment showed similar results. In Yates 2005 sec-
ondary outcomes were not reported due to non-significant results.
In Henderson 2012 only major significant study outcomes were
reported (with no data for distress and mental adjustment to can-
cer). The impact of selective reporting in these four studies was
therefore unclear and this domain was judged as unclear risk of
bias.
Other potential sources of bias
In 19 trials the information provided about this domain was suf-
ficient and as a result this domain was judged as low risk of bias.
In the remaining nine trials there was insufficient information to
permit a clear judgement in this domain. Because of the non-ther-
apeutic nature of the intervention, none of the studies reported
any conflict of interest with pharmaceutical companies.
Effects of interventions
See: Summary of findings for the main comparison Cognitive
behavioural therapy versus control for womenwith non-metastatic
breast cancer
Cognitive behavioural therapy (CBT) versus control
There were 24 studies that compared these intervention groups
(Andersen 2004; Antoni 2001; Antoni 2006; Baucom 2009;
Boesen 2011; Cohen 2007; Dolbeault 2009; Ferguson 2012;
Fillion 2008; Fukui 2000;Garssen 2013;Graves 2003;Henderson
2012; Kissane 2003; Loprinzi 2011; Manne 2007; Marchioro
1996; Mishel 2005; Narváez 2008; Nunes 2007; Richardson
1997; Simpson 2001; Taylor 2003; Yates 2005).
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Primary outcomes
Mean difference in depression
We identified nine studies that included this outcome. Seven stud-
ies carried out a group-delivered intervention and measured the
mean difference (MD) in depression using any validated disease
specific tool at the end of the study (Ferguson 2012; Fukui 2000;
Garssen 2013; Henderson 2012; Kissane 2003; Narváez 2008;
Nunes 2007); and two carried out an individually-delivered inter-
vention (Marchioro 1996; Yates 2005).
From the nine studies with this outcome, seven studies were in-
cluded in our analysis, five compared a group-delivered interven-
tion to placebo and two an individually-delivered intervention
compared to placebo. The pooled change from baseline standard-
ised mean difference (SMD) comparing the group and individu-
ally-delivered interventions to standard care was -1.01 (95% CI -
1.83 to -0.18; P = 0.02; I2 = 95%; Chi2 test P < 0.00001) (Analysis
1.1; Figure 3) but the estimate was associated with a high level of
uncertainty due to severe heterogeneity, which was introduced by
Garssen 2013. After the removal of Garssen 2013 in a sensitivity
analysis, the SMD was -0.43 (95% CI -0.90 to 0.04; P = 0.07; I2
= 82%; Chi2 test P < 0.0001) (Analysis 1.2).
Figure 3. Forest plot of comparison: 1 CBT versus control, outcome: 1.1 Standardised mean difference for
the change from baseline in depression.
Whilst there was non-significant statistical evidence showing a
within group reduction in depression from baseline following the
group-delivered intervention compared to control, themajority of
the studies exhibited modest positive effects favouring CBT. We
rated this result as low quality evidence due to inconsistency in the
magnitude of effect across the studies, unexplained heterogeneity
introduced by one study (Garssen 2013), absence of allocation
concealment in two studies and unclear risk of bias in the remain-
ing studies with respect to the same domain.
Mean difference in anxiety
Eight studies reported the change in anxiety with the intervention
delivered as either a group intervention (Dolbeault 2009; Fukui
2000; Garssen 2013; Kissane 2003; Loprinzi 2011; Narváez 2008;
Nunes 2007) or an individually-delivered intervention (Yates
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2005). The eight studies included 393 patients in the intervention
arm and 383 in the control arm. The change from baseline pooled
SMD between the intervention and control on the anxiety scale
was -0.48 (95% CI -0.76 to -0.21; P = 0.0006; I2 = 64%; Chi2
test P = 0.006) (Analysis 1.3; Figure 4). This suggested reduced
anxiety in the CBT group compared to control but the substantial
heterogeneity left doubt over the comparability of these studies.
Figure 4. Forest plot of comparison: 1 CBT versus control, outcome: 1.3 Standardised mean difference for
the change from baseline in anxiety.
We rated this result as low quality evidence because allocation
concealment was not done in two studies whereas it was judged as
unclear risk of bias in the remaining included studies.
Mean difference in stress
Two studies reported the mean difference in stress (Antoni 2006;
Nunes 2007). However, no estimate of the variability was reported
and we were unable to estimate it in one study (Antoni 2006).
No meta-analyses were carried out. In Antoni 2006, 92 patients
were allocated to the intervention arm and 107 to the control arm.
The intrusion subscale of the Impact of event scale was used to
measure stress and showed a significant reduction in distress over
time with CBT relative to the control condition (both arms had a
reduction in stress from baseline but the reduction with CBT was
greater). This effect persisted at nine months post-intervention.
In Nunes 2007, 20 patients were allocated to the intervention
arm and 14 to the control arm. The experimental group showed
significantly reduced levels of stress from baseline measured by
Lipp’s Inventory of Stress Symptoms in adults (P < 0.05). The
scoring was performed by means of three different stages related
to the duration (Q1 = last 24 hours, Q2 = last week and Q3 = last
month). Q1, for example, showed a within group reduction from
baseline in the score (mean ± SD) for stress in the intervention
group from 4.11 ± 2 to 2.79 ± 1.65.
Mean difference in mood disturbance
Ten studies reported the change in mood with CBT delivered
as a group intervention (Andersen 2004; Boesen 2011; Classen
2008; Dolbeault 2009; Fillion 2008; Fukui 2000; Graves 2003;
Henderson 2012; Kissane 2003) or an individually-delivered in-
18Psychological interventions for women with non-metastatic breast cancer (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
tervention (Mishel 2005). Sufficient data were available from eight
studies across all subgroups with 755 participants allocated to the
intervention and 781 to the control arm. The SMD between in-
tervention and control was -0.28 (95% CI -0.43 to -0.13; P =
0.0003; I2 = 47%; P = 0.07) (Analysis 1.4; Figure 5). This sug-
gested consistent evidence that CBT, delivered either in a group
or on an individual basis, resulted in within group reduction from
baseline in mood disturbance compared to control. There was no
evidence to suggest any difference in interventional effect across
the three subgroups (P = 0.43; I2 = 0%).
Figure 5. Forest plot of comparison: 1 CBT versus control, outcome: 1.4 Standardised mean difference for
the change from baseline in mood disturbance.
We rated the quality of evidence as moderate because three or
more domains of risk of bias including allocation concealment
were judged as unclear risk of bias in the included studies. In two
studies (Classen 2008; Kissane 2003) allocation concealment was
not done.
Secondary outcomes
Mean difference in quality of life (QoL)
Nine studies reported the change in QoL in a group-delivered
(Boesen 2011; Dolbeault 2009; Ferguson 2012; Fillion 2008;
Garssen 2013; Graves 2003) or individually-delivered interven-
tion setting (Baucom 2009; Loprinzi 2011; Yates 2005). In these
studies, 351 women were allocated to the intervention arm and
368 to the control arm. There appeared to be differences between
the subgroups that were indicative of an important difference be-
tween the subgroups for this outcome. However, this view was
not confirmed by the P value of 0.17. The SMD for the group-
delivered intervention was 0.21 (95% CI -0.03 to 0.46; P = 0.08;
I2 = 47%; Chi2 test P = 0.09) (Analysis 1.5; Figure 6) and for the
individually-delivered intervention the SMD was 0.65 (95% CI
0.07 to 1.23; P = 0.03; I2 = 41%; Chi2 test P = 0.18).
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Figure 6. Forest plot of comparison: 1 CBT versus control, outcome: 1.5 Standardised mean difference for
the change from baseline in quality of life.
We rated the quality of evidence as low in the group-delivered
intervention because in three studies one ormore of the risk of bias
domains, including allocation concealment, was judged as unclear
risk of bias and four different tools were used tomeasureQoL. The
individually-delivered intervention was rated as very low evidence
because in the three included studies at least four domains of risk
of bias including allocation concealment were judged as unclear
risk of bias and each study used a different tool to measure the
outcome.
Mean difference in coping
Six studies reported the change in coping when CBT was deliv-
ered either as a group intervention (Dolbeault 2009; Fukui 2000;
Graves 2003; Henderson 2012; Simpson 2001) or as an indi-
vidually-delivered intervention (Marchioro 1996). No data could
be extracted to carry out a pooled meta-analysis, but two studies
(Graves 2003; Marchioro 1996) with data are shown in Analysis
1.6. The total number of participants in these two studies was
33 in the intervention arm and 35 in the control arm. The inter-
vention showed significant improvement in the treatment arm in
Fukui 2000, Graves 2003, Simpson 2001 and Marchioro 1996
and no significant difference in Dolbeault 2009 and Henderson
2012.Mental Adjustment to Cancer was the most frequently used
tool to measure coping. However, several versions and subscales
were used. For example, all five scales were used in Fukui 2000 and
Simpson 2001 whereas two scales were used in Dolbeault 2009.
Other studies utilised other tools such as the Cancer Behaviour
Inventory (Graves 2003), adaptation to cancer (Marchioro 1996)
and dealing with illness (Henderson 2012).
Mean difference in adjustment
One study reported the change in coping adjustment delivered as
a group intervention (Boesen 2011). In this study 102 patients
were allocated to the intervention arm and 103 to the control arm.
The authors used the Mental Adjustment to Cancer instrument
which has five domains (fighting spirit, helplessness and hopeless-
ness, anxious preoccupation, cognitive avoidance and fatalism) but
none of the five domains suggested any evidence of a difference
between the intervention and control groups.
Overall survival
Three studies reported on overall survival (Andersen 2004; Boesen
2011;Kissane 2004).One study didnot describe their data because
only nine deaths were experienced (Boesen 2011).
From the remaining two studies included in the analysis 268 pa-
tients were allocated to the intervention group and 262 were al-
located to control. In Andersen 2004 54 of 227 (24%) women
had died, 24 in the intervention arm and 30 in the assessment
only arm. Breast cancer was the primary cause of death for 44 of
the 54 patients (19 patients from the intervention arm and 25
from the assessment only arm). In Kissane 2004 the Kaplan-Meier
analysis revealed a median survival of 81.9 months (95% CI 64.8
to 99.0) in the intervention group compared with 85.5 months
(95%CI 67.5 to 103.6) in the control arm. Information regarding
the number of deaths in each arm was not reported.
The pooled hazard ratio (HR) from two studies (Andersen 2004;
Kissane 2004) was 0.76 (95%CI 0.25 to 2.32; P = 0.63; I2 = 84%;
Chi2 test P = 0.01) but exhibited substantial heterogeneity, so the
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generalisability of this result should be considered with caution
(Analysis 1.7). We rated the quality of evidence as low because
allocation concealment was absent in one of the two included
studies and at least two other risk of bias domains were judged as
unclear risk of bias in addition to the substantial heterogeneity.
Adverse events
No studies reported on adverse events.
Subgroup analysis
Dose of psychological intervention (≤ 20 hours versus > 20 hours)
was tested for the outcomes and the overall treatment effect. Only
anxiety andmood disturbance outcomes showed significant results
favouring the shorter intervention (≤ 20 hours versus > 20 hours).
However, one should be very cautious interpreting this result as
the long intervention was evaluated in only a handful of included
studies (Kissane 2003; Loprinzi 2011).
Psychotherapy versus control
There were four studies that compared psychotherapy and control
(Badger 2007; Classen 2008; Marcus 2010; Vos 2004).
Primary outcomes
Mean difference in depression
Three of the four studies reported depression outcomes. Badger
2007 reported the mean difference in depression using the Cen-
ter for Epidemiological Studies-Depression Scale (CES-D). The
participants in the intervention arm (n = 38) showed a decrease
in the depression score (mean ± SD) from 16.44 ± 1.74 to 8.82 ±
1.81 at 10 weeks whereas the participants in the control arm (n =
33) showed an increase in the depression score from 9.88 ± 1.79
to 14.25 ± 1.76. No meta-analyses were carried out.
Marcus 2010 reported depression using the CES-D. The study
included 152 participants in the intervention arm and 152 in
the control arm. For depression, the mean scores for both groups
showed a significant reduction over time, with no difference by
experimental group in the change from baseline. In contrast, when
these scores were dichotomised a dramatically different pattern
emerged. The control group showed no significant change from
baseline to 18 months (P = 0.41) whereas the intervention group
showed significant improvement (P = 0.0007) reflecting about a
50% reduction in the percentage scoring at or above the cutpoint
suggestive of the need for a clinical referral. Group differences in
change from baseline to 18 months approached statistical signifi-
cance (P = 0.06) with an effect size of 0.23.
In Classen 2008, depression was one of the secondary outcomes,
which was measured using the Hospital Anxiety and Depression
Scale (HADS). The study included 177 women in the interven-
tion arm and 175 in the control arm. It showed beneficial effects
of treatment on the depression scale using both the model with
imputed data and the reduced model F (1,253) = 5.4, P = 0.021
and F (1,212) = 6.3, P = 0.013, respectively.
Mean difference in anxiety
Two studies reported on anxiety. Badger 2007 reported the mean
difference in anxiety. In this study, 38 women were allocated to the
intervention arm and 33 to the control arm. Participants in the
intervention arm showed a reduction in the anxiety score (mean
± SD) from 3.05 ± 0.34 to 2.81 ± 0.29 at 10 weeks of follow-up
whereas the control arm reported a decrease from 4.39 ± 0.33 to
3.19 ± 0.28. No meta-analyses were carried out.
In Classen 2008, anxiety was one of the secondary outcomes that
was measured using the HADS. The study included 177 women
in the intervention arm and 175 in the control arm. It showed
beneficial effects of treatment on the anxiety scale using both the
model with imputed data and the reduced model F (1,253) = 4.5,
P = 0.034 and F (1,212) = 3.9, P = 0.049, respectively.
Mean difference in stress and distress
Only one study reported ondistress.Marcus 2010 reported distress
using the Impact of event scale (intrusive subscale only). Mean
scores for both groups showed a significant reduction over time,
with no difference by experimental group in the change from base-
line. In contrast, when these scores were dichotomised a dramati-
cally different pattern emerged. The control group showed no sig-
nificant change from baseline to 18 months (P = 0.41) whereas the
intervention group showed significant improvement (P = 0.0007),
reflecting about a 50% reduction in the percentage scoring at
or above the cutpoint suggestive of the need for a clinical refer-
ral. Group differences in change from baseline to 18 months ap-
proached statistical significance (P = 0.07) with an effect size of
0.24.
Mean difference in mood disturbance
Classen 2008 reported on mood disturbance using the POMS
scale. The study included 177 women in the intervention arm and
175 in the control. It showed a decrease in the POMS score in the
intervention arm from a mean of 27.59 (SD 32.11) at baseline
to 19.54 (SD 30.65) at 6 months and a further decrease to 13.69
(SD 30.67) at 24 months. On the other hand, the participants
in the control arm showed a decrease in the POMS score from a
mean of 21.67 (SD 29.07) at baseline to 16.36 (SD 32.18) at 6
months and a further decrease to 9.05 (SD 26.19) at 24 months.
However, no significant effect was seen in POMS score between
the two arms when the outlier observation was removed from the
analysis.
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In Vos 2004, 69 women with early stage breast cancer were ran-
domised in a psychosocial group intervention program starting
within 4 months after surgery (n = 34) or in the waiting list con-
trol (n = 35). It was not possible to extract the data as they were
presented in a regression model.
Secondary outcomes
Mean difference in quality of life (QoL)
No studies reported this outcome.
Mean difference in coping
Vos 2004 reported on coping using a shortened 19 item version
of the Utrecht Coping List in a study that included 69 women
with early stage breast cancer randomised to a psychosocial group
intervention program starting within 4 months after surgery (n =
34) or to the waiting list control (n = 35). It was not possible to
extract the data as they were presented in a regression model.
Mean difference in adjustment
In Classen 2008, adjustment was one of the secondary outcomes
that was measured using the Mini-Mental Adjustment to Cancer
scale. This study showed beneficial effects of treatment on the
adjustment scale using both the model with imputed data and the
reduced model F (1,253) = 5.2, P = 0.024 and F (1,212) = 5.3, P
= 0.022, respectively.
Overall survival and adverse events
No studies reported these outcomes.
D I S C U S S I O N
Summary of main results
Psychological outcomes
Meta-analysis showed significantly improved scores for anxiety,
mood disturbance and depression favouring the psychological in-
tervention (cognitive behavioural therapy). On the other hand,
the intervention showed significant improvement on quality of life
only in an individually-delivered format. Group-delivered inter-
ventions appearedmore beneficial for depression andmood distur-
bance outcomes. Both forms of intervention (group and individ-
ual) were associated with significantly reduced anxiety compared
to control. Although the shorter intervention (≤ 20 hours) showed
favourable results for the anxiety andmood disturbance outcomes,
one should be very cautious interpreting this finding due to the
limited number of studies evaluating high doses of the interven-
tion (> 20 hours). Further studies comparing various doses of the
therapy are needed before making any conclusive judgement.
Survival
Psychological interventions for women with non-metastatic breast
cancer were not associated with survival. This finding is based on
two studies involving 530 women (pooled HR 0.76, 95% CI 0.25
to 2.32; P = 0.63; I2 = 84%).
Overall completeness and applicability of
evidence
This review considers randomised controlled trials (RCTs) of a
wide range of psychological therapies for breast cancer (seeTypes of
interventions). Studies included participants from different coun-
tries and backgrounds who had been diagnosed with, and treated
for, breast cancer (see Types of participants). Many factors, how-
ever, limit the generalisability of the results.Most studies were con-
ducted in the USA and Europe, limiting generalisability of results
to the rest of the world. Although we have included the full range
of psychological therapies for breast cancer, insufficient data pre-
clude meta-analysis of a number of outcomes in some treatment
groups. There are a larger number of studies of group cognitive
behavioural intervention than for other therapies. All studies but
one (Andersen 2004) did not include participants with comorbid
psychiatric diagnoses such as depression and anxiety therefore ex-
cluding individuals who are arguably more difficult to treat. This
may have resulted in the exclusion of individuals with high levels
of stress who are more or less likely to benefit from the treatment.
Quality of the evidence
The trials were heterogeneous inmany of the clinical and method-
ological characteristics which could potentially affect the direc-
tion and magnitude of the effect. The main areas of heterogeneity
are type of intervention, control condition, inclusion criteria, out-
come measurement, timing of follow up and quality of studies.
Type of intervention
A wide range of psychological interventions was used and in most
cases a combination of two or more approaches and techniques
have been employed making it by far the most challenging factor
when comparing various studies. Additionally, details on the con-
tent and integrity of the intervention were not always available.
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Control condition
Studies used standard care control conditions and did not control
for the potential effect of non-specific structured activities taking
place at home or at a hospital. Variation in standard care in the
various trials should also be taken in to consideration when com-
paring trials conducted in different settings.
Inclusion criteria
Although previous reports showed that womenwith higher level of
psychological disturbances benefited the most from psychological
interventions compared to standard care, all but one trial excluded
women with psychological morbidities. Even when women with
higher levels of distress were included in the trial, they were rarely
analysed separately.
Outcome measurement
There is a huge variation in the instruments used to assess vari-
ous outcomes in the trials included in this review. Most tools are
validated but a few are not. One should be cautious interpreting
the results originating from different tools although measuring the
same outcome.
Timing of follow up
There is a good body of literature showing that the longer time that
has elapsed after diagnosis the better the psychological status of
women is. Therefore, timing of measuring the outcome can make
a difference in the magnitude and direction of the effect of the
intervention. The included trials showed a considerable amount
of heterogeneity in the timing of outcome assessments hence this
should be taken into consideration when comparing trials with
early and late assessments.
Quality of studies
One of themajormethodological issues with this kind of interven-
tion is that blinding of interventionists and patients is not possible
due to the nature of the intervention. The absence of blinding
on the magnitude and direction of the treatment effect is unclear
and could potentially have led to performance bias. Although only
RCTs were included in this review, four studies provided insuffi-
cient details on allocation concealment and nine trials reported in-
sufficient details on sequence generation. Considering the nature
of the intervention, which is primarily a preventive psychological
intervention as opposed to a drug intervention, pharmaceutical
company funding did not constitute a threat.
Potential biases in the review process
This review was conducted in line with the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011). Although
the methodology for conducting systematic reviews is well estab-
lished, subjective judgement is inevitable throughout the process.
The main limitation of this review is the lack of sufficient data in
many trials to make a clear judgement in various bias domains. As
a result, a false estimate of the underlying truth is inevitable. An-
other limitation is the heterogeneity in the intervention delivered,
outcomemeasurement, timing of followup and participants’ char-
acteristics. The paucity of data, especially for the survival outcome,
resulted in ambiguous study specific effect estimates. Addition-
ally, because most of the included trials were primarily conducted
among Caucasians and in developed countries, generalisability of
the results to different ethnic groups and countries might not be
feasible. Finally, the cut-off of 20 hours used in the subanalysis
is almost certainly arbitrary with no ’scientific’ rationale as such.
This cut-off was used for comparison purposes with a previously
conducted systematic review in the same field (Naaman 2009).
One of the important limitations is that adverse outcomes to the
intervention were not reported in the included trials. The iatro-
genic effect of psychological intervention has scarcely been studied
(Barlow 2010; Roback 2000). For example, one study showed that
peer discussion groups had a negative effect on women with breast
cancer (Helgeson 1999). One should note that in this review we
included only professional-led well described interventions and
not peer group discussions. Nevertheless, the possibility of the in-
tervention causing harm cannot be ruled out by the reported data.
Agreements and disagreements with other
studies or reviews
We identified few meta-analyses investigating psychological inter-
vention in women with breast cancer (Duijts 2011;Mustafa 2013;
Matsuda 2014; Naaman 2009). However, the inclusion criteria
were not uniform across the reviews. They varied drastically in
terms of the stage of the disease, type of intervention and the out-
come measured. For example, Naaman et al included women at
early and late stage of the disease (Naaman 2009), Duijts et al
investigated behavioural techniques and physical exercise (Duijts
2011), Matsuda confined the search to English-language trials
(Matsuda 2014) and Mustafa et al included only women with
metastatic breast cancer (Mustafa 2013). There is considerable de-
bate over the effect of psychological intervention on survival. Most
meta-analyses of data from cancer patients found no survival ben-
efit of such intervention (Chow 2004; Cwikel 1998; Newell 2002;
Smedslund 2004; Zabalegui 2005). In line with the vast literature,
our analysis showed no significant survival benefit for psycholog-
ical intervention in women with non-metastatic disease. In con-
trast, Mustafa et al reported a favourable effect of the intervention
on survival at one year but this was not sustained at five years
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(Mustafa 2013). There is general agreement amongst researchers
in the field that consistent long-term reporting of the effects of psy-
chological interventions on survival is necessary (Mustafa 2013;
Newell 2002; Smedslund 2004; Williams 2006).
Consistent with previous reviews on cancer patients (Jacobsen
2008; Meyer 1995; Osborn 2006; Raingruber 2011; Reshe 2003)
and reviews on women with breast cancer (Naaman 2009), our
results showed favourable effects of psychological interventions on
some psychological outcomes, particularly anxiety. However, no
significant effect was found on quality of life (QoL), which is in
agreement with some but not all reviews for patients with cancer
(Newell 2002) and breast cancer (Matsuda 2014). Nevertheless, a
small improvement was achieved in QoL when the disease specific
measurement tool was used (Galway 2012). The benefits for psy-
chological outcomes seem to be less evident when the disease has
already metastasised to other parts of the body (Mustafa 2013).
It is noteworthy that in some reviews depression was used inter-
changeably with mood disturbance. As a result, data originating
from tools used to measure mood disturbance were pooled under
depression as an outcome. This might explain the discrepancy in
the effect size for depression. This also applies to other outcomes
such as stress, distress, coping and adjustment. The variation in the
terminology used to describe various psychological outcomes and
the interchangeably make it difficult to classify and subsequently
pool the trials.
Similar to a previous review on patients with breast cancer
(Naaman 2009), our result shows that group therapy was generally
superior to individual therapy for the treatment of anxiety and
depression. However, this was not uniform across other reviews in
which all cancer patients were included (Osborn 2006). This con-
troversy might be related to the differences in patients included
and the scarcity of trials investigating individually-delivered inter-
ventions.
CBT carried the most beneficial effect, however one should be
cautious interpreting this result because of the insufficient number
of trials investigating other forms of psychological intervention
and the inconsistency in defining what constitutes psychotherapy
and other forms of psychological intervention.
Although in a previous review (Naaman 2009) a treatment dura-
tion time of greater than 20 hours compared to less than 20 hours
yielded significant results, it was not possible to examine this sub-
grouping in this review because only one trial fulfilled the long
duration criteria (Kissane 2003).
There are indications that psychological interventions targeting
patients at higher level of stress have greater clinical benefit than
when targeting women with low or normal levels of stress (Sheard
1999). It was not possible to investigate this relationship in this
review due to the paucity of studies that included patients with
such a profile. Furthermore, even when patients with a higher level
of distress were included, their results were not reported separately.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Psychological interventions appear to be effective in improving
some psychological symptoms in women with non-metastatic
breast cancer, particularly when group CBT is utilised. However,
the effect on survival is debatable and not established in this review.
It seems more sensible for healthcare providers to offer therapy
aimed at reducing psychological distress as opposed to enhancing
survival. We could only make relatively tentative recommenda-
tions about the effectiveness of psychological interventions in en-
hancing patient outcomes taking into consideration the method-
ological shortcomings of the included trials.
Implications for research
There is an abundance of research in this area. However, more
attention should be paid to maximizing internal validity. Special
attention should be given to randomisation and allocation con-
cealment. Blinding might be difficult to achieve with psychologi-
cal interventions but blinding the assessors is possible and would
add to the rigour of the studies. We also suggest that future trials
recruit an adequate sample size to detect a statistically significant
effect. Meticulous definitions and descriptions of the psychologi-
cal interventions and use of standardised outcome measurements
are fundamental to allowing for meaningful pooling of data. Deci-
sions about the type of intervention, measurement tool, duration
of follow up and outcome assessment should take into account
the existing reviews. Additionally, the sustainability of the effect
of the psychological intervention needs to be assessed in long term
RCTs.
Future research must target women presenting with clinically im-
portant levels of anxiety and depression to confirm the potential
favourable clinical effect in this subgroup of the population as rec-
ommended by the international guidelines for psycho-oncology
(Coleman 2011).
Finally, it is time that more focus and attention is given to the
possible adverse effects of psychological interventions in order that
we can better understand the settings and situations in which such
interventions are best not used. This is in light of the preliminary
results from observational studies showing a possible increase in
stress associated with psychological intervention. Therefore, more
rigorous trials are needed to confirm or reject this hypothesis.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Andersen 2004
Methods Method: RCT
Setting: USA
Duration of intervention: 4 months
Participants N = 227 (114 intervention arm, 113 control arm)
• Power analyses suggested a total number of 200 patients, and 227 patients were
accrued
Participants were chosen using two methods:
• Consecutive patients at a university affiliated National Cancer Institute-
designated Comprehensive cancer centre (n = 189)
• Self- and physician-referred patients from the community (n = 38)
• The overall accrual was 57%
Inclusion criteria
• Women who were diagnosed with stage II or III breast cancer
• Surgically treated, and awaiting adjuvant therapy
Exclusion criteria
• Prior cancer diagnosis
• Refusal of cancer treatment
• Age less than 20 years or more than 85 years
• Residence more than 90 miles from the research site
• Diagnoses of mental retardation, severe or untreated psychopathology (eg
schizophrenia), neurologic disorders, dementia
• Any immunologic condition or disease
Interventions • The intervention was conducted in small patient groups (range 8 to 12 patients),
with one session per week for 4 months (Andersen 2004)
• The intervention was over 12 months, weekly session (1.5 hours) for 4 weeks then
monthly session for 8 months. Total 26 sessions (39 hours) (Andersen 2007 and
Andersen 2008)
• The sessions included strategies to reduce stress, improve mood, alter health
behaviours, and maintain adherence to cancer treatment and care
• Each session was conducted by two clinical psychologists. Cohorts met weekly for
1.5 hours for 18 sessions (27 therapy hours during 4 months)
• The topics and techniques used were consistent with psychosocial interventions
but also included diet, exercise, smoking, and adherence components
• Participants completed 94% of the intervention session
Outcomes Andersen 2004 and Andersen 2007:
1. Emotional distress by the POMS assessed negative mood. A Total Mood Disturbance
score was the sum of five scales (anxiety, depression, anger, fatigue, and confusion) minus
the score of a vigour scale
2. Stress by Impact of event scale
• Assessment at baseline and 4 months (Andersen 2004)
• Collected at baseline, 4 months, and 12 months (Andersen 2007)
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Andersen 2004 (Continued)
Andersen 2008:
3. Survival and recurrence: breast cancer specific survival defined as the time from ran-
domisation to breast cancer death. Disease recurrence was defined as the detection of
metastatic disease either at the same site (local) or distant from the original site
Notes • Baseline assessment occurred before randomisation and adjuvant therapy
• Analyses of socio-demographic variables and disease or prognostic factors or
treatments received or planned revealed no significant differences between study arms
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients were randomly assigned to either
the intervention group or assessment only
group” “White and Freedman’s minimiza-
tion method was used for randomization”
Comment: this was judged at a low risk of
bias
Allocation concealment (selection bias) Low risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
After e-mail communication with investi-
gators:
“There would have been no way for them
to know who was going into the interven-
tion until they came to the group interven-
tion as a third person was in charge of the
allocation process”
Comment: this was judged as adequate
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The method used in blinding the outcome
assessment was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
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Andersen 2004 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk The numbers and reasons for dropouts and
withdrawals (12.7%) from each groupwere
reported and balanced across both groups
Recurrence status was known for 93% (212
of 227 patients) of the patients, and mor-
tality was known for 100%
Analyses contrasting participants versus
non-participants found no significant dif-
ferences between study arms
Data analysed using intention-to-treat
analysis
Comment: we judged this as at a low risk
of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Comment: we judged this as at a low risk
of bias
Other bias Low risk The authors indicated no potential con-
flicts of interest
Comment: we judged this as at a low risk
of bias
Antoni 2001
Methods Design: RCT
Setting: USA
Duration of intervention: 10 weeks
Participants • A total of 136 randomised and 100 women analysed (47 intervention, 53 control)
• Stage 0 to II
• Participants were recruited from clinics through an invitation letter from their
physicians, flyers
• Of the women contacted by letter, 80% called for more information; of those
who called, 98.6% of those who met inclusion criteria participated in initial assessment
Inclusion criteria
• Stage II or below
• Surgery within the last 8 weeks
Exclusion criteria
• Prior cancer
• Prior psychiatric treatment
• Major concurrent disease
• Lack of English fluency
Interventions • Intervention arm: 10-weeks of 2 hour group cognitive behavioural stress
management group intervention led by trained post-doctoral fellows
• The control arm had a day seminar (5 to 6 hours)
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Antoni 2001 (Continued)
• Began 6 to 8 weeks after surgery
Outcomes • Depression by CES-D (Centre for Epidemiology Studies-Depression) (also a
clinical cut-off point of 16 was used to indicate clinically significant depression)
• Emotional distress (general mood disturbance) by POMS (only three subscales
used, anxiety, depression and anger) and an average score was calculated
• Baseline, post-treatment, at 3 months post-intervention, 9 months post-
intervention
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomly assigned”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel is
not possible in this type of intervention
Comment: the effect of lack of blinding
on outcome in this type of intervention is
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Assessmentswere handled by graduate stu-
dents who were not conducting the inter-
vention with that cohort”
Comment: this was judged as at a low risk
of bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Out of 136,11 dropped out at post-inter-
vention, 9 dropped out at 3 months,16
dropped at 9 months and 100 completed
all assessments
136 randomised, 100 analysed (26.4%
dropout rate)
Comparison between dropout and women
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Antoni 2001 (Continued)
who stayed in trial showed no difference
Comment: although the numbers of drop-
outs were balanced between the groups, the
percentage of dropouts and subsequent per
protocol analysis posed an unclear risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Comment: we judged this as at a low risk
of bias
Other bias Low risk Research grant fromNational Cancer Insti-
tute and training grant from Department
of Defence
Comment: we judged this as at a low risk
of bias
Antoni 2006
Methods Design: RCT
Setting: USA
Duration of intervention: 10 weeks
Participants • N = 199 (92 intervention, 107 control)
Inclusion criteria
• Women with stage 0 to III breast cancer
• Had surgery within the past 8 weeks
Exclusion criteria
• Prior cancer
• Prior psychiatric treatment for serious disorders for a serious disorder
(hospitalisation or a formal diagnosis of psychosis, major depressive episode, panic
attacks, suicidality, or substance dependence
• Lack of fluency in English
Interventions • Cognitive Behavioural Stress Management versus 5 to 6 hours educational seminar
• Intervention: 10 week (2-hour) group sessions of cognitive behavioural stress
management
• Began 10 to 12 weeks after surgery
• Intervention and control seminars were led by female post-doctoral fellows and
advanced pre-doctoral trainees in clinical psychology
Outcomes • Collected at study entry, 6 months and 12 months after entry
• The second assessment occurred 3 months after the intervention ended (6 months
after the initial assessment). A third assessment occurred 6 months later. Thus the
period of follow-up spanned approximately 1 year after random assignment
• Thought intrusion and avoidance (Impact of event scale) indicator of event
related distress
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Antoni 2006 (Continued)
• Interviewer-rated anxiety (Hamilton Rating Scale for anxiety)
• Emotional distress (Affects Balance Scale)
Notes “Most women were completing adjuvant therapy by the second assessment, the third
assessment reflects the durability of this effect”
Participants were self selected
Women were not excluded for elevated levels of anxiety or depression
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomly assigned”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Assessments were handled by persons who
did not conduct the intervention with that
cohort”
Comment: this was judged as low risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition did not differ significantly by con-
dition at Time 2, or Time 3
Dropout was 21% (42/199), 18 in the in-
tervention group and 24 in the control
group
Quote (page 1792): “We used an intent-to-
treat analysis, estimating missing data us-
ing full information maximum likelihood.
Thus, the entire sample was represented in
all analyses”
“At each time point, those who dropped
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Antoni 2006 (Continued)
out were compared on key variables with
those retained”
Comment: we judged this as at a low risk
of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Research Grant from National Cancer In-
stitute
Co-authors reported no competing interest
Comment: we judged this as at a low risk
of bias
Badger 2007
Methods Design: RCT
Setting: USA
Duration of intervention: 6 weeks
Participants • N = 96 and their partners
Eligibility criteria
• Diagnosis of Stage I to III breast cancer,
• Currently receiving adjuvant treatment for breast cancer
• Ability to speak English and talk on the telephone
• No physical or psychological disabilities that would prevent participating in the
intervention
• Availability of a partner who was willing to participate
Interventions Telephone-delivered psychosocial interventions
Six-week programs: (a) telephone interpersonal counselling (TIP-C) n = 38 women and
38 partners; (b) self-managed exercise n = 23; or (c) attention control n = 37
TIP group received weekly phone calls, 34 minutes on average
All interventions were delivered by counsellors trained in the intervention for which they
were responsible
Outcomes Assessment done at T1 baseline, T2 (T1 + 6 weeks), T3 (T1 + 10 weeks)
Depression by 20-item Center for Epidemiological Studies V Depression Scale (CES-
D)
Anxiety by generated anxiety index (an eight-item composite index of anxiety was
formed). The composite anxiety index was expressed on a 1 to 10 scale, with high scores
indicating greater anxiety
Notes • Sample recruited from a local cancer centre, oncologists’ offices, support groups,
and through self-referral after reading brochures displayed in various settings
Risk of bias
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Badger 2007 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The project director randomly assigned,
stratified by stage and treatment, women
and their partners”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
After e-mail communication with investi-
gators: “We generated a table of the two
conditions randomly assigned to randomly
generated subject identification numbers”
Comment: this was judged as adequate
Allocation concealment (selection bias) Low risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
After e-mail communication with investi-
gators: “Only the PI and the program co-
ordinator had access to the allocation pro-
cedure. The other researchers did not”
Comment: this was judged as adequate
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk There was insufficient information to per-
mit a clear judgement of risk of bias
After e-mail communication with investi-
gators: they answered “the outcome assess-
ment was done by data collectors who had
no knowledge of the arms nor were they
involved in the design.”
Comment: this was judged as adequate
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk In the intervention group 37/37 were anal-
ysed, in the control group 33/37 analysed,
attrition rate at 4/37(10.8%)
The numbers and reasons for dropouts and
withdrawals from each groupwere reported
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Badger 2007 (Continued)
and were balanced across both groups
Dropouts were excluded from analysis so
per protocol analysis was done
Comment: although the numbers of drop-
outs were balanced between the groups and
the percentage of dropouts was low, subse-
quent per protocol analysis posed an un-
clear risk of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Comment: this was judged as at a low risk
of bias
Other bias Low risk Funding provided by theNational Institute
of Nursing Research
Comment: this was judged as at a low risk
of bias
Baucom 2009
Methods Design: pilot RCT
Setting: USA
Duration of intervention: 6 weeks
Participants • 14 couples (8 intervention and 6 control)
Inclusion criteria
• Recently diagnosed with stage I or II breast cancer
• No history of other breast cancer
• No history of cancer within the last 5 years
• Currently married or living together with a male romantic partner for at least 12
months
• Both partners willing to participate and able to speak English
Interventions • Couple-based relationship enhancement (RE) (n = 8) or treatment as usual (TAU)
(n = 6)
• RE condition attended six bi-weekly, face-to-face, 75-min sessions with a therapist
Outcomes • Distress Brief Symptom Inventory-18 (BSI-18 higher score indicates more
distress)
• Quality of life by Functional Assessment of Cancer Therapy (FACT-B)
• Assessments were conducted before treatment, post-treatment, and 12 months
later
Notes These couples were 13% of eligible couples who were contacted for the study
Risk of bias
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Baucom 2009 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Using a computer-based random num-
ber generator, a staff member randomly as-
signed couples to one of the two treatment
conditions after the initial assessment was
completed”
Comment: this was judged at a low risk of
bias
Allocation concealment (selection bias) Unclear risk Both couples and assessors were blinded to
treatment assignment
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The method used in blinding the outcome
assessment was not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Two were dropped from analysis. One cou-
ple from the intervention because they felt
the intervention did not meet their needs.
One control woman died from breast can-
cer between posttest and follow-up. Thus,
their data were excluded from the protocol
analyses at the relevant time periods
Comment: this was judged as at an unclear
risk of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Supported by a grant from the National
Cancer Institute and a grant from the
Lineberger Comprehensive Cancer Center
at the University of North Carolina
43Psychological interventions for women with non-metastatic breast cancer (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Boesen 2011
Methods Design:RCT
Setting: Denmark
Duration of intervention: 10 weeks
Participants N = 210 (intervention 102, control 103)
Inclusion criteria:
• 18 to 70 years of age
• Stages I to IIIA primary breast cancer
• Diagnosed and treated at the University Hospital of Copenhagen, Herlev,
Denmark
Interventions Two weekly 6-hour sessions of psycho-education and 8 weekly 2-hour sessions of group
psychotherapy
The intervention had two parts:
• The first was 12 hours of education at the outpatient clinic, conducted as 2-
weekly sessions
• In the second part of the intervention, groups of eight women met 8 times over 8
weeks for 2.5-hour sessions in a cancer counselling clinic
Outcomes Measured at 1, 6 and 12 months after the intervention
Distress was measured by The Profile of Mood States short form scale
Mental Adjustment was elicited by the Mental Adjustment to Cancer scale
Quality of life was assessed from the QLQ-C30 core questionnaire of the European Or-
ganisation for Research and Treatment of Cancer (EORTC)34 and the complementary
breast cancer module EORTC QLQ-BR23.35
Survival at 4 years. The overall survival of all patients was determined from the unique
personal identification number assigned by the Central Population Register to all Danish
residents who were alive on 1 April 1968 or born thereafter
All women were followed from the date of operation for breast cancer until the date of
death or end of follow-up (31 May 2009)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote page 1364: “randomised to the in-
tervention or the control group in the fol-
lowing way: via the Internet, the nurse
logged onto the database of the project
which was housed in the Danish Cancer
Society, typing the number of the base-
line questionnaire. This number became
the number of the patient and the ran-
domisation status would appear. The num-
ber of the questionnaire was not known to
the nurse before a sealed envelope with the
questionnaire was broken by the patient.”
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Boesen 2011 (Continued)
Comment: this was judged as low risk of
bias
Allocation concealment (selection bias) Low risk Quote page 1364: “The number of the
questionnaire was not known to the nurse
before a sealed envelope with the question-
naire was broken by the patient.”
Comment: this was judged as low risk of
bias
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of the lack of blinding
on outcome in this type of interventionwas
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 205 randomised and 176 analysed
19 dropped out for various reasons men-
tioned in the paper
CONSORT diagram presented on page
1365
Comment: although the numbers of drop-
outs were balanced between the groups, the
percentage of dropouts and subsequent per
protocol analysis posed an unclear risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Supported by the Psychosocial Research
Committee, the Danish Cancer Society,
the IMK Foundation and the University of
Southern Denmark
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Classen 2008
Methods Design: RCT
Setting: USA (nine Community Clinical Oncology Program practice groups in the
community and two academic sites, Stanford University and the University of Rochester
Duration of intervention: 12 weeks
Participants N = 353
Inclusion criteria
• Diagnosis of primary, biopsy proven breast cancer, stages I through IIIA
• Diagnosis occurred no more than 12 months prior to recruitment
• Completion of initial surgical treatment
• No detectable disease present
Exclusion criteria
• Evidence of metastases beyond adjacent lymph nodes
• Diagnosis of other cancers (except for basal cell or squamous cell carcinoma of the
skin or in situ cervical cancer) within the past 10 years
• Any other major medical problems likely to limit life expectancy to less than 10
years
• Major psychiatric illness for which the patient was hospitalised or medicated,
except for a diagnosis of depression or anxiety treated for a period of less than one year
• Attendance at a cancer support group for more than two months
Interventions • 12-week supportive-expressive group therapy (n = 177) versus education control
(n = 176)
• Groups met weekly for 12 weeks. Each meeting lasted 90 min and was composed
of up to 10 members and two co-therapists. On average, women attended 8 out of 12
sessions
Outcomes • Six different time points: baseline (before randomisation), 3 (immediately post-
intervention), 6, 12, 18 and 24 months
• Mood disturbance by Profile of Mood States Questionnaire (POMS)
• Anxiety and depression by the Hospital Anxiety and Depression Scale (HADS)
• Adjustment by Mini-Mental Adjustment to Cancer Scale (MAC)
Notes • Of those women who were invited to participate in this trial, the acceptance rate
was approximately 25% at rural sites and 35% to 45% at urban sites
• There were no differences between the randomised treatment and control groups
(N = 177 and N = 176, respectively) at baseline on demographic or medical status
variables except for stage of disease
• Only one third of the sample met the cut-off for high distress at entry
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Random assignment followed a method
combining elements of biased coin ran-
domisation with adaptive randomisation”
Comment: this was probably done and
judged as at a low risk of bias
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Classen 2008 (Continued)
Allocation concealment (selection bias) High risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement. We e-
mailed the trialist who replied that there
was no allocation concealment in this study
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias. We e-mailed the trialist
After e-mail communication with investi-
gators: “Assessment was by patient comple-
tion of standard questionnaires who were
aware of their assignment”. Because pa-
tients were aware of their assignment this
was judged as at high risk of bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Figure 1 page 441 described the number
and reasons for dropouts
Comment: although the numbers of drop-
outs were balanced between the groups, the
percentage of dropouts and subsequent per
protocol analysis posed an unclear risk of
bias
Selective reporting (reporting bias) Unclear risk These measures were mentioned in the
methods but were not reported in results
“Courtauld Emotional Control Scale, Im-
pact of Event Scale, Stanford Self-Efficacy
Scale for Serious Illness, CARES Medical
Interaction Subscale, Family Relations In-
dex, SleepMeasure adapted from the Stan-
ford Sleep Questionnaire and Assessment
of Wakefulness, Pain Measure and Yale So-
cial Support Index”
Comment: this was judged as at an unclear
risk of bias
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Classen 2008 (Continued)
Other bias Unclear risk There was an uneven distribution of high
and low distressed participants
There were no declarations of potential
conflicts of interest or indication of fund-
ing or support
Comment: there was insufficient informa-
tion reported to assess whether there were
other sources of important risk of bias
Cohen 2007
Methods Design: RCT
Duration of follow up: 4 months
Setting: oncology department that covers cancer patients from the northern area of Israel
Participants N = 114 (CBT 38, relaxation and guided imagery 39, standard care 37)
Inclusion criteria
• Early stage breast cancer stage I and II who were 2 to 12 months since surgery
• Receiving treatment, chemotherapy or radiotherapy
• Speaking Hebrew
• Absence of a psychiatric illness
Interventions Cognitive behaviour therapy (n = 38) versus relaxation and guided imagery (n = 39)
versus control (standard care) (n = 37)
• Delivered by senior social worker with experience in psycho-oncology
• Each group comprised 6 to 8 participants who met weekly for nine (90-minute)
sessions for 3 months
Outcomes • Assessment done at pre-intervention, post-intervention, at the end of 4-month
follow up
• Psychological distress by Brief symptom inventory
• Stress by Perceived Stress Scale
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “Women were randomly assigned to one of
three groups”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
After e-mail communication with investi-
gators:“When a women agreed to partici-
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Cohen 2007 (Continued)
pate, she was allocated to one of the groups
1, 2, 3 in a systematic order”
Comment: this was judged as inadequate
Allocation concealment (selection bias) High risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
After e-mail communication with investi-
gators: “The allocation was done by a nurse
who did not take a part in the study and it
was totally concealed from the researchers”
Comment: this was judged as inadequate
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote (page 316): “The assessors were not
aware of participants’ group affiliation, and
their data were obtained and analysed in-
dependently of the intervention”
“the author who conducted the interven-
tions kept strictly away from all procedures
of data collection and data recording on the
computer”
Comment: this was judged as at a low risk
of bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “Demographic and clinical characteristics
of the active participants in each of the
groups and of those who dropped out are
comparable and presented in Tables 1 and
2”
170 agreed to participate and 26 declined.
14 from the relaxation and guided imagery
group and 16 from the cognitive behaviour
group were not included in the analysis
Comment: although the numbers of drop-
outs were balanced between the groups, the
percentage of dropouts and subsequent per
protocol analysis posed an unclear risk of
bias
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Cohen 2007 (Continued)
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Unclear risk There were no declarations of potential
conflicts of interest or indication of fund-
ing or support
Comment: there was insufficient informa-
tion reported to assess whether there were
other sources of important risk of bias
Dolbeault 2009
Methods Design: RCT
Setting: 3 French cancer centres
Participants N = 203 (102/101)
Inclusion criteria
• 18 years or older
• Completed primary breast cancer treatment (radiation alone or combined
chemoradiotherapy 15 days to 1 year before testing)
• No recurrence or metastases
• Had working knowledge of French
• No psychiatric diagnosis such as severe cognitive disorders, mood disorders
(ongoing or recent history of depression requiring hospitalisation) or serious
personality disorder
Interventions • 102 in the psycho-education group versus 101 in the waiting list
• Led by two therapists, either psychologists or psychiatrists, 8 (2 hour) group
sessions of cognitive behavioural therapy
Outcomes • One week before starting the immediate intervention (E1), the second after
completion of the intervention (E2) after 8 sessions, and the third after 1 month of
completion ie one week before the beginning of the deferred intervention (E3)
• Stress by State-Trait Anxiety Inventory (STAI) (whose scores range from 20 to 80
with a higher score reflecting a higher level of anxiety)
• Depression by Profile of mood states (POMS), total score and subscales scores
were calculated
• Coping by the Mental Adjustment to Cancer scale (MAC)
• QoL by EORTC QLQ-C30,BR23 (administered only at E1 and E3 to reduce
evaluation fatigue)
Notes • Only 20% of those approached by letter answered positively
• After randomisation, patients who dropped out were not replaced
• Patients who missed four group sessions were excluded from the analyses
Risk of bias
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Dolbeault 2009 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Women were randomised”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Low risk “Randomization by sealed letter was per-
formed at each site, with a readjustment of
the number of subjects in each group after
every eighth subject”
Comment: this was judged as at a low risk
of bias
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote (page 468): “patients who dropped
out were not replaced. Patients who missed
four group sessions were excluded from the
analyses”
Quote (page 654): “lack of complete data
for one-fifth of the patients, who did not
complete the questionnaires at all three
evaluation times”
Overall dropouts 35/203 (17.2%) (21%
dropped out from intervention and 14%
from control) andwere excluded from anal-
ysis
Comment: although the numbers of drop-
outs were balanced between the groups, the
percentage of dropouts and subsequent per
protocol analysis posed an unclear risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
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Dolbeault 2009 (Continued)
Other bias Low risk This research received a grant fromaFrench
Hospital Programme of Clinical Research
Comment: this was judged as at a low risk
of bias
Ferguson 2012
Methods Design: RCT
Setting: Dartmouth-Hitchcock Medical Center, USA
Participants N = 40
Intervention = 19, wait list control = 21
Inclusion criteria
• Adult female breast cancer survivors:
◦ Received adjuvant chemotherapy for stage I and II
◦ Were at least 18 months post-treatment currently disease free (not excluding
individuals on hormonal therapies such as selective oestrogen receptor modulators or
aromatase inhibitors)
◦ Treatment involved standard dose adjuvant chemotherapy
◦ Complaint of memory and attention problems following chemotherapy
◦ Able to speak and read English
◦ At least 18 years of age at diagnosis and able to provide informed written
consent
Exclusion criteria
• History of Central Nervous System (CNS) disease
• History of CNS radiation
• Intrathecal therapy or CNS-involved surgery
• Neuro-behavioural risk factors such as traumatic brain injury, history of
neurological disorder
• Learning disability or substance addiction
• Current psychiatric disorder
Interventions • Memory and Attention Adaptation Training (MAAT) was a brief cognitive
behavioural therapy (CBT) aimed at enhancing cancer survivor skills for self-managing
and coping with cognitive failures of daily life, four biweekly individual office visits
• 30 to 50 min in duration with phone contacts between visits
Outcomes Measured at baseline, post-treatment, 2-month follow up
QoLmeasured byQuality of Life-Cancer Survivors (QOL-CS), higher scores represented
better outcomes
Depression by Center for Epidemiological Study-Depression (CES-D)
Anxiety by Spielberger State-Trait Anxiety Inventory (STAI)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Ferguson 2012 (Continued)
Random sequence generation (selection
bias)
Low risk Quote page 178: “randomized to treatment
and wait list conditions using computer
generated assignment”
Comment: this was judged as low risk of
bias
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote page 178: “The research assistant
completing all assessment and testing was
blind to participant group membership”
Comment: this was judged as low risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 40 randomised, intervention 19 and con-
trol 21, 2 dropped out from intervention
and 3 dropped out from control, attrition
rate 12.5%
Quote page 178: “These participants did
not differ significantly from the final sam-
ple demographic or dependent variables”
Missing data were accounted for using lin-
ear interpolation
Comment: interpolation may potentially
lead to type I error the effect of which was
unclear so this was judged as unclear risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Funded by a grant from the Lance Arm-
strong Foundation
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Fillion 2008
Methods Design: RCT
Setting: Canada
Duration of intervention: 3 months
Participants N = 94 (intervention 48, control 46)
Inclusion criteria
• Non-metastatic breast cancer
• Completed their initial breast cancer treatment no longer than 2 years before
enrolment
• Received 1 series of adjuvant treatments of radiotherapy, or having received
radiotherapy in combination with other adjuvant treatments (eg chemotherapy or
hormonal therapy)
• Understanding and speaking French
• Passing the revised Physical Activity Readiness Medical Examination
• Living near the cancer centre and being available to take part in a series of 4-
weekly sessions
• Accepting the randomisation procedure
Exclusion criteria
• Showed clinical levels of depression symptoms
• Insomnia
• Any symptoms of recurrence
• Any known severe health problems other than cancer
Interventions 48 intervention, 46 control
• The intervention was composed of 4-weekly group meetings of 2.5 hours and 1
short telephone booster session (5 to 15 minutes), stress and fatigue management
program
Outcomes • Follow up at baseline, after intervention 5 weeks and 3 months
• Quality of life by the Medical Outcomes Study Short Form 12. It provides 2
scores: a mental health and a physical health component
• Emotional distress combines the mean scores of the anxiety and depression
subscales of the Profile of Mood State
Notes • Of the 498 patients eligible and invited to participate, 149 (30%) showed interest
in participating in the study
• 94 (19%) participants met all eligibility criteria and were randomly assigned to
the study conditions
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote (page 153): “The sequence of ran-
domisationwas computer generated, after a
preliminary stratification, according to the
adjuvant treatments received”
Comment: this was judged as at a low risk
of bias
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Fillion 2008 (Continued)
Allocation concealment (selection bias) Low risk Quote (page 152): “randomly assigned
each participant to either the control or
experimental group using sealed envelopes
which were concealed to both kinesiologist
and patient until then.”
Comment: this was judged as at a low risk
of bias
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Of 94 subjects, 7 withdrew for reasons re-
ported on the flowchart (Figure 1, page
149), 87 analysed
Comment: although the numbers of drop-
outs were balanced between the groups and
the percentage of dropouts was low, subse-
quent per protocol analysis posed an un-
clear risk of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Unclear risk “Significant differences between groups
were observed for the following variables:
employment status, physical activity level,
physical menopausal symptoms, cancer
stage, hormonal therapy, and partial and
total mastectomy”
Supported by grant from the “Fonds de
recherche en sante´ du Quebec” and by an
Investigator Award to Lise Fillion
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Fukui 2000
Methods Design: RCT
Setting: National Cancer Center Hospital East, Japan
Duration of intervention: 6 weeks
Participants N = 50 (25 intervention, 25 control)
Inclusion criteria
• Younger than 65 years
• Identified and informed of being at higher risk of recurrence (defined as lymph
node metastasis positive or histologic or nuclear grade 2 to 3, or both)
• Surgery within the previous 4 to 18 months
• No chemotherapy or completed chemotherapy
Exclusion criteria
• Severe mental disorders or dementia
• If they had cancer at another site diagnosed
Interventions • The intervention consisted of health education, coping skills training, stress
management, and psychologic support
• 6 weekly 1.5 hour group intervention led by a psychiatrists and a clinical
psychologist
• Waiting list control group
Outcomes • Psychological distress by Profile of Mood States (POMS)
• Coping by Mental Adjustment to Cancer (MAC) scale
• Anxiety and depression by Hospital Anxiety and Depression (HADS) scale
Assessment done at baseline, at 6 weeks, and at 6 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote (page 1027): “Participants were ran-
domly assigned to either an experimental
group or a wait-list control group by using
a table of random numbers.”
Comment: this was judged as at a low risk
of bias
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk “We were unable to blind the participants
to treatment allocation”
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Fukui 2000 (Continued)
Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcomes in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Four dropped out (8%), two of them in
the intervention arm, reasons mentioned.
“The dropouts were not significantly dif-
ferent regarding any demographic or clini-
cal variables or any dependent measures at
the baseline from those who completed all
assessments”
Comment: although the numbers of drop-
outs were balanced between the groups and
the percentage of dropouts was low, subse-
quent per protocol analysis posed an un-
clear risk of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Unclear risk • Small sample size
• There was a significant difference in
age between the subjects who participated
and those who did not
• Supported by a Grant-in-Aid for
Cancer Research and Second-Term
Comprehensive 10-Year Strategy for
Cancer Control from the Japanese
Ministry of Health and Welfare, Japan.
Also was supported by the Fumiko Yamaji
Trust for Academic Nursing Education
and Research, Tokyo, Japan
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Garssen 2013
Methods Design: RCT
Setting: Medical Centre Alkmaar, Netherlands
Duration of intervention: 4 sessions
Participants N = 85 (42 intervention, 43 control)
Inclusion criteria
• Clinically-proven breast cancer stage I to III
Exclusion criteria
• Age > 75 years
• Serious psychiatric disorder
• Immune-related comorbidity
• Other malignant tumours now present
• Chemotherapy or immunotherapy
• Use of steroid medicines, Primperan or non-steroid anti-inflammatory drugs
Interventions • The intervention delivered was Stress Management Training consisting of four
sessions of relaxation, guided imagery techniques, and counselling that aimed to
promote active coping, alert relaxation, and a positive attitude to change. The training
sessions were conducted by the same trained clinical psychologist
• The control group received care as usual without any contact with the
psychologist who delivered the training in the intervention group
Outcomes Measured at 6 measurement points: Day 6 and Day 1 pre-surgery, and Day 2, 5, 30 and
90 post-surgery
• Anxiety: the state scale from the State-Trait Anxiety Inventory
• Depression by the eight-item depression subscale from the Profile of Mood States
was used (POMS)
• Quality of life by the three general quality of life questions from the European
Organization for Research and Treatment of Cancer Core Quality of Life
Questionnaire (EORTC)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote page 573: “Subjects were randomly
assigned to the intervention and control
condition by using block randomization.
The first week, patients were allocated to
the intervention condition and the next
week to the control condition”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
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Garssen 2013 (Continued)
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Dropouts = 15 for reasons mentioned in
figure 2 page 576
Comment: although the numbers of drop-
outs were balanced between the groups and
the percentage of dropouts was low, subse-
quent per protocol analysis posed an un-
clear risk of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Financed by the Dutch Cancer Society
Graves 2003
Methods Design: pilot randomised two group design
Setting: US
Duration of intervention: 8 weeks
Participants N = 32 (15 intervention, 17 control)
Women of any stage within the past five years were included but none of them were at
stage IV of the disease
Age was not specified
Interventions Intervention versus standard care
The intervention: 8 sessions of social cognitive theory, that is, one session (1.5 hour/
session) for 8 weeks
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Graves 2003 (Continued)
Women assigned to the intervention ~n = 15 attended the program in small groups
Outcomes Collected at baseline and post-test
• QoL assessed by Functional Assessment of Cancer Therapy-Breast (FACT-B)
• Mood assessed by Profile of Mood States (POMS)
• Coping assessed by Cancer Behaviour Inventory (CBI)
Notes For the post-test only 7 completed the test in the intervention arm and 7 in the control
arm
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Women were randomised to either the
skill-building intervention or standard care
control group
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
High risk • For the post-test only 7 completed
the test in the intervention arm and 7 in
the control arm
• Women who completed post-test did
not differ from the 18 women who did
not complete the study on any
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Graves 2003 (Continued)
demographic or clinical characteristics
• Women who completed the
intervention appeared to be more
distressed at baseline than women who
dropped out of the study
• Baseline differences between women
who completed the program and those
who did not complete the program were
evident across all variables
• The consistent finding that all of the
baseline scores were lower for completers
was intriguing
• Dropout 14/32 = 44%
Comment: the high dropout rate and per
protocol analysis posed a high risk of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Comment: this project was funded in part
by the Graduate Student Association of
Virginia Tech
Henderson 2012
Methods Design: RCT
Setting: USA
Duration of intervention: 8 weeks
Participants N = 172 newly diagnosed (within the past two years) stage I or II cancer of the breast
Inclusion criteria
• Between 20 and 65 years of age
• Capable of understanding informed consent in English
• Planned to maintain residence in the study area for at least two years following
recruitment
• Eastern Cooperative Oncology Group performance status 0, 1, or 2 (ie able to
function normally 50% of the time); were willing to accept randomisation
• Had a working home telephone
• Willing to be contacted
Exclusion criteria
• Previous diagnosis of cancer in the past 5 years, except non-melanoma skin cancer
• Current chronic substance abuse (either drug or alcohol)
• Past or present psychiatric or neurologic disorder that would preclude or severely
limit participation in the study
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Henderson 2012 (Continued)
Interventions Three-arm RCT
Mindfulness-based stress reduction (MBSR) (n = 58) versus nutrition education program
(n = 52) versus usual supportive care (n = 53)
MBSR included elements consistent with cognitive behavioural therapy, group support,
experiential focus, and a strong educational orientation
Intervention included 7weekly 2.5 to 3.5-hour sessions and one 7.5-hour intensive silent
retreat session in the sixth week
Outcomes Follow-up was performed at three post-intervention points: 4 months, 1, and 2 years
• Cancer specific QoL, as measured by the breast cancer version of the Functional
Assessment of Cancer Therapy (FACT-B)
• Coping mechanisms, measured by the Dealing with Illness questionnaire (focuses
on three broad dimensions of coping strategies: (a) active behavioral coping (b) active
cognitive coping; and (c) avoidance coping)
• Depressive symptoms, measured by the Beck Depression Inventory-I (BDI)
• Anxiety symptoms, measured by the Beck Anxiety Inventory (BAI)
• General distress, measured by the Symptom Checklist- 90-Revised (SCL-90-R)
• Cancer specific coping and emotional responses were measured by the short form
of the Mental Adjustment to Cancer Scale (Mini-MAC)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Women were block randomised by stage of
disease (I or II), by age (± 5 years) within
menopausal group, and by institution
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
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Henderson 2012 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropouts = 17 out of 180, attrition rate (9.
4%)
Analyses were conducted using both inten-
tion-to-treat (ITT), which only takes into
account whether or not a subject was ran-
domised, and post-hoc analyses in which
models were fit that included information
on co-variates from subjects who provided
data at each measurement point
Comment: this was judged as low risk of
bias
Selective reporting (reporting bias) Unclear risk No data for distress and mental adjustment
to cancer
Other bias Unclear risk Funded by grant from the US Army Med-
ical Research and Materiel Command Ca-
reer Development Award
Established Investigator Award in Cancer
Prevention and Control
Kissane 2003
Methods Design: RCT
Setting: oncology departments of nine metropolitan hospitals in Melbourne, Australia
Duration of intervention: 20 weeks
Participants N = 303 (154 intervention, 149 control)
Inclusion criteria
• Age under 65
• Histologically confirmed diagnosis of early stage breast cancer, operational English
• Geographic accessibility
Exclusion criteria
• Prior history of cancer (other than non-melanocytic skin cancers)
• Psychotic illness
• Dementia and intellectual disability
Interventions Intervention versus control
• The intervention: cognitive-existential group therapy, 20 sessions one session/
week for 90 minutes plus three relaxation classes
• Intervention group consisted of 6 to 8 patients
• Control consisted of 3 relaxation classes
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Kissane 2003 (Continued)
Outcomes • Assessed at baseline, 6 months, 12 months
• Change in affective state by Affects Balance Scale (ABS)
• Anxiety and depression by Hospitals Anxiety and Depression Scale (HADs)
• Adjustment to cancer by Mental Adjustment to Cancer scale (MAC)
Kissane 2004
• Survival: patients’ medical records were reviewed at 3 and 5 years after
recruitment. Dates of confirmed recurrence or death were recorded
Notes Baseline assessment of psychiatric disorder in control and intervention; no significant
differences found
”On an intention-to-treat analysis, there was a trend for those receiving group therapy
(n = 154) to have reduced anxiety compared to controls (n = 149)“
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”Randomisation was independently di-
rected by our statistician, using a computer-
generated allocation schedule“. Stratified
on nodal status, hormone receptor status,
and tumour size
Comment: this was judged as at a low risk
of bias
Allocation concealment (selection bias) High risk ”The blinding of research assistants to the
randomisation allocation is not method-
ologically possible in research of this type“
Comment: this was judged as at a high risk
of bias
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported in Kissane 2003. Quote: ”Trained
research assistants conducted baseline and
follow-up assessments“
In Kissane 2004, quote (page 4256): a dif-
ferent research assistant, who was blinded
to randomization, reviewed patients’ med-
ical records at 3 and 5 years after recruit-
ment”
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias in Kissane 2003
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Overall dropout rate (less than 6 sessions)
from group therapy was 12%, reasons for
and numbers of dropouts found in figure 1
page 534
Intention-to-treat analysis was performed
Comment: the intention to treat analy-
sis and balanced dropouts between groups
poses a low risk of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Supported by funding grants from the Re-
search and Development Grants Advisory
Committee of the Australian Common-
wealth Department of Health and Human
Services, the National Health and Medical
Research Council of Australia and the Pratt
Foundation
Loprinzi 2011
Methods Design: RCT
Setting: USA
Duration of intervention: 12 weeks
Participants N = 24 (12 intervention versus 12 wait list)
Inclusion criteria
• Being a Pink Ribbon Mentor
• Able and willing to participate in all aspects of the study
• Signed the appropriate informed consent form
Exclusion criteria
• Recent (within past 6 months) psychotic episode
• Clinically significant acute unstable neurologic, psychiatric, hepatic,renal,
cardiovascular, or respiratory disease that prevented participation in the study
Interventions Two 90-minute group session, a 30 to 60-minute brief individual session and 3 phone
calls lasting 15 minutes
Stress Management and Resiliency Training
Outcomes Measured at baseline and 12 weeks
Stress by Perceived Stress Scale
Anxiety by Smith Anxiety Scale
QoL by Linear Analog Self Assessment Scale
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were divided with the help of a
random number generator, into 2 groups:
an active arm and a wait list control arm
Comment: this was judged as low risk of
bias
Allocation concealment (selection bias) Unclear risk Twenty-four patients were randomised in
single-blind, wait list controlled clinical
trial
The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
After e-mail communication with investi-
gators: “The allocation sequence was con-
cealed to the researchers”
Comment: this was judged as insufficient
information about the method of conceal-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention.
The interventionist knew which partici-
pants belonged to which group
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
After e-mail communication with investi-
gators: “Data assessors and statistician were
blinded”
Comment: the method used for blinding
was unclear so this was judged as at unclear
risk of bias
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Incomplete outcome data (attrition bias)
All outcomes
High risk No attrition in the intervention group but
attrition rate in control group was 33.3%
(4 out of 12 dropped)
Comment: the high attrition rate in the
waitlist arm and the per protocol analysis
posed a high risk of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Funded by the SponsorshipResearchCom-
mittee, Mayo Clinic College of Medicine
Manne 2007
Methods Design: RCT
Setting: USA
Duration of intervention: 6 weeks
Participants N = 238 (120 intervention, 118 usual care)
Inclusion criteria
• Diagnosed with early stage breast cancer
• Undergone breast cancer surgery within the last six months
• Eastern Cooperative Oncology Group ECOG status of 0 or 1
• Married or cohabitating with a significant other
• 18 years of age or older
• English-speaking
Interventions Intervention n = 120 and Control n = 118
Intervention: 6-weekly 90-minute sessions (6 sessions of a couple-focused group)
Outcomes • Assessment at pre-intervention (time 1), 1 week post-intervention (time 2), and 6
months post-intervention (time 3)
• General distress: by Mental Health inventory (MHI)
• Cancer specific distress: by Impact of Event Scale (IES)
Notes • There were no differences between participants and refusers in terms of ethnicity
or cancer stage but participants were younger and had higher performance on ECOG
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Participants were randomly assigned”
“Participants were randomised in blocks of
14”
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Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Low risk • Of the 238 participants, 201
completed post-intervention surveys (84.
5%) and 174 completed 6-month follow-
up surveys (73%)
• Attrition analysis showed that
participants who dropped were
significantly younger, married for a
shorter duration and had more physical
impairment, had higher ECOG ratings
• There were no significant differences
in survey completion rate across
conditions
• ITT analysis was done
Comment: this was judged as at a low risk
of bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Unclear risk There were no declarations of potential
conflicts of interest or indication of fund-
ing or support
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Comment: there was insufficient informa-
tion to permit a clear judgement of the risk
of bias
Marchioro 1996
Methods Design: RCT
Setting: Italy
Duration of intervention: Not specified
Participants N = 36 (18 intervention, 18 control)
Inclusion criteria
• Women with non-metastatic breast cancer assigned to chemotherapy
• Upper age limit 65 years
• No history of psychiatric illness
• No prior history of cancer
• Ability to read and communicate in Italian
Interventions Intervention versus control
The intervention: psychological intervention (weekly individual 50-minute cognitive
psychotherapy sessions plus bimonthly family counselling)
All sessions were delivered by same psychologist
Outcomes QoL and depression measured at initial evaluation, after 1, 3, 6 and 9 months
• QoL by Functional living Index cancer
• Depression by beck depression Inventory
• Adaptation to cancer by 16-PF, A form and Index Introject Questionnaire
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Patients were randomly assigned to inter-
vention versus no intervention
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
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tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 36/40 participated (3 showed low compli-
ance, 1 refused consent)
It was not clear if data analysis was per pro-
tocol or intention to treat
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Unclear risk Comment: there was insufficient informa-
tion reported to assess whether there were
other sources of important risk of bias
Marcus 2010
Methods Design: RCT
Setting: USA
Duration of intervention: 12 months
Participants N = 304 (152 Intervention, 152 control)
Inclusion criteria
• Stage 1, 2 and 3 disease (with no greater than 10 positive lymph nodes involved)
• Completed treatment for breast cancer
• No evidence of overt psychosis or suicidal behaviour
• Treatment plan does not include bone marrow transplantation
• Not currently enrolled in another quality of life intervention study
• Can receive the counselling sessions and assessment questionnaires in English
Interventions 152 intervention, 152 control
• The intervention group received a one-year, 16 session telephone counselling
program augmented with additional print. The 16 counselling sessions lasted on
average about 45 minute each delivered by four Masters-level psychosocial oncology
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counsellors
• The control group received a resource directory for breast cancer
Outcomes • Distress by Intrusion sub-scale of Impact of Event Scale
• Depression by Center for Epidemiologic Studies Depression Scale
• Assessments at baseline, and at 3, 6, 12 and 18-month intervals
Notes • Of 354 eligible women, 304 (86%) agreed to participate and were subsequently
enrolled
• There were no differences by experimental condition on any of the socio-
demographic variables
• Similarly, there were no differences on any of the health status or breast cancer
diagnostic or treatment variables obtained at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomized two-group design”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The response rates at each follow-upwere as
follows: 3months 93%(n=282); 6months
88% (n = 266); 12 months 86% (n = 261)
; 18 months 80% (n = 243)
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22% (n = 34) declined to complete the pro-
gram. Most of the dropouts occurred dur-
ing or immediately following session one
(44%), or after sessions two or three (36%)
. When participants dropped out from the
counselling program, theywere encouraged
to complete the follow-up questionnaires,
and 71% (n = 24) complied. These data
were included in all analyses
Comment: absence of data from the re-
maining 10 drop out poses unclear risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk 86% of breast cancer patients approached
for study enrolment agreed to participate
The research reported herein was sup-
ported by a grant from the National Can-
cer Institute
Mishel 2005
Methods Design: RCT
Setting: USA
Duration of intervention: 4 weeks
Gil 2006 is a substudy reporting the outcomes after 10 months from baseline
Participants Mishel 2005: N = 509 (244 intervention, 265 control)
Gil 2006: only 483 completed the trial at T3
Inclusion criteria
• African American and Caucasian 5 to 9 years post-treatment
• Recurrence free
• No concurrent treatment, could be on tamoxifen
• Had a telephone and planned to reside in their current community for 2 years
following entry into the study
Interventions • Four-weekly telephone sessions guided by a nurse
• Cognitive strategies delivered via audiotapes and behavioural strategies via self-
help manual
• Control (usual care) group: no attempt was made to limit their exposure to
naturally occurring learning contexts such as media, public health programs
• Nurses guided women through the intervention over the course of four weekly
30-min telephone call
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Outcomes • Psychological distress by profile of mood states short form (POMS-SF)
• Coping by modified version of the cognitive Coping Strategies Questionnaire
(CSQ)
• T1 at baseline and T2 10 months after baseline
• 20 months post-baseline (T3) was reported in Gil 2006
Notes • A total of 1053 eligible women were contacted as potential participants. Of these,
575 or 55% agreed to participate
• There were no significant differences at baseline between women in the
intervention and control groups
• “Since these women were 5-9 years post-treated, it might be expected that they
would not be disturbed by triggers of recurrence fears and by long-term treatment side
effects”
• Those who participated were significantly younger, and the participation rate for
African American women was higher than for White women
• “The study utilized a standard care control condition and therefore did not
control for potential non-specific effects such as time spent with a nurse or time spent
at home on a structured activity”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomised to interven-
tion or control. SAS programProc Planwas
used to construct a randomisation plan
Comment: this was judged as at a low risk
of bias
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition rate was 11% with 66 dropouts
575 agreed to participate and only 509
completed T2 (89% of those who entered
the study was retained)
“Five percent of women (n = 15 in inter-
vention; n = 11 controls) were not included
at follow-up due to dropout, unable to con-
tact, and so on”
In Gil 2006: “the 20-month follow-up
sample represented 95% (n = 483) of the
509 women” this should be from 575 who
first entered the study and not those who
retained at T2; 483/575 = 84%
Comment: although the numbers of drop-
outs were balanced between the groups, the
percentage of dropouts and subsequent per
protocol analysis posed an unclear risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk This was supported byNational Cancer In-
stitute
Narváez 2008
Methods Design: RCT
Setting: Madrid, Spain
Duration of intervention: 9 weeks
Participants N = 38 (19 intervention, 19 control)
Inclusion criteria
• Diagnosis of breast cancer
• To be currently disease free and to have been so for three years
• To have undergone a mastectomy in the last three years and to be currently
receiving hormonal therapy as the sole treatment
• Minimum age of 30 and maximum age of 60 years
Exclusion criteria
• Presence of prior psychopathology that requires treatment with specific
medication
• Presence of active disease
• To be in a phase of active treatment (except for hormonal therapy)
Interventions 19 intervention, 19 control
Nine weekly 90-minute sessions of structured cognitive behavioural group therapy
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Outcomes • Depression assessed by Beck Depression Inventory (BDI)
• Anxiety measured by The State Anxiety Scale from the State-Trait Anxiety
Inventory (STAI)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The women were assigned to the groups
randomly”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
After e-mail communication with investi-
gators: “randomization was simple random
sampling and not used any software”
Comment: this was judged as inadequate
Allocation concealment (selection bias) High risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
After e-mail communication with inves-
tigators:“randomization was performed by
one of the researchers and the result was
known by all researchers”
Comment: this was judged as at high risk
of bias
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk After e-mail communication with investi-
gators: “randomization was blind for pa-
tients and not blind for researchers”
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Blinding of outcome assessment was not re-
ported. There was insufficient information
to permit a clear judgement of risk of bias
After e-mail communication with investi-
gators: “the results of the investigation were
known to researchers”
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Comment: this was judged as at high risk
of bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No dropouts were reported. It was not clear
if data analysis was per protocol or inten-
tion to treat
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Unclear risk There were no declarations of potential
conflicts of interest or indication of fund-
ing or support
Comment: there was insufficient informa-
tion to permit a clear judgement of the risk
of bias
Nunes 2007
Methods Design: RCT
Setting: Radiotherapy Service at São Lucas Hospital (Porto Alegre, Brazil)
Duration of the study: 24 days
Participants N = 34 (20 intervention, 14 control)
Inclusion criteria
• Subjects with breast cancer (stage I or II) undergoing radiotherapy
Exclusion criteria
• Presence of acute or chronic:
◦ Heart disease
◦ Anorexia
◦ Anemia
◦ Leucopenia
◦ Clinical depression
◦ Post traumatic stress disorder
◦ Neurodegenerative disease
◦ Use of glucocorticoids
Interventions • Intervention (n = 20) relaxation and visualization therapy (RVT) for 24
consecutive days or control group (n = 14) who were on radiotherapy only
• The RVT intervention consisted of 24 daily, 30-minute structured group (n less
than 4) sessions at the Breast Cancer Unit
• The subjects were always led by the same trained investigator (psychologist) at all
times
• The RVT included a relaxation period (20 minute), in which the subject was
induced to mentally create an image of the desired objective or result, included
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progressive muscle relaxation, guided imagery, meditation, and deep breathing
Outcomes • Stress by the Lipp Stress Symptoms Inventory for adults (LSSI)
• Anxiety by The State Trait Anxiety Inventory (STAI) and Beck Anxiety Inventory
(BAI)
• Depression by The Beck Depression Inventory (BDI)
• Assessment done at baseline and after 24-day intervention
Notes Patients of the experimental group were more anxious than the control group at baseline
Had at least 2 weeks of chemotherapy washout
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Subjects were randomly assigned into two
groups”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “All subjects completed the two assess-
ments”
No dropouts were reported. It was not clear
if data analysis was per protocol or inten-
tion to treat
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Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Unclear risk There were no declarations of potential
conflicts of interest or indication of fund-
ing or support
Comment: there was insufficient informa-
tion to permit a clear judgement of the risk
of bias
Richardson 1997
Methods Design: (pilot) prospective experimental pre-test post-test study design
Setting: USA
Study duration: 6 weeks
Participants N = 47
Inclusion criteria
• Diagnosed with breast cancer (excluded stage IV)
• Post-operative > 6 weeks
• Chemotherapy and radiation completed (> 1 month and < 30 months)
• Stayed in Houston area
• Understood English
• > 18 years of age
Exclusion criteria
• On corticosteroid therapy
• Known psychiatric disease
• Active substance abuse
• Evidence of heart disease
• Tamoxifen
• Immune disorder
Interventions Standard care (15) versus support group (16) versus imagery (16)
Support group: (6 weekly group sessions) not psychotherapy but aimed at decreasing
stress, sharing feelings, enhance self-esteem delivered by social workers
Imagery and relaxation: 5 weekly (1 hour group sessions) and 1 hour individual session
delivered by psychotherapist, social worker and hypnotherapist
Designed to develop imaging ability, breathing techniques, relaxation skills, role of im-
mune system, setting goals, coping with fears, giving and receiving support
Outcomes • Outcome measured before randomisation and after last session
• Coping: ways of coping with cancer assesses the type and frequency of coping
strategies used over the past 6 months to deal with the most stressful aspect of a cancer
diagnosis
• QoL by FACT-B
• Emotional well-being: Profile of Mood States-brief
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Notes Methodology paper: Moye LA, Richardson MA, Post-White J, Justice B. Research
methodology in psychoneuroimmunology:rationale and design of the IMAGES-P clin-
ical trial. Alternative Therapies in Health and Medicine 1995:1(2):34-9
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomly assigned”
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Subjects and interventionist know the ex-
perimental group status
Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Only evaluators of immunoassays were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Follow-up was complete with no attrition
(there were partial attendants n = 4, that is,
those who missed one or more session)
Selective reporting (reporting bias) Low risk All outcomes were reported
Other bias Low risk Supported by grants from the National In-
stitute of Health and National Cancer In-
stitute
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Methods Design: RCT
Setting: Tom Baker Cancer Centre, Canada
Duration of intervention: 6 weeks
Participants N = 89 (46 intervention, 43 control)
Inclusion criteria
• Completed treatment for stage 0 to III
• Diagnosed after 1992 up to 2 years post-treatment
• Age < 70 years
Exclusion criteria
• Older than 70 years
• Residence more than 40 km from the cancer centre
• Diagnosis earlier than Jan 1992
• Tumour stage III or IV
• More than one diagnosis of cancer or active chronic illness
• Psychotic illness or active substance abuse
Interventions • Intervention 46 versus control 43
• Intervention: 6 weeks of CBT (90 minutes) led by psychiatrist
• Group size 7 to 10
• Control: received information package
Outcomes • Assessment done at pre-intervention, immediately post-intervention, 1 year and 2
years
• Depressive symptoms by Beck Depression inventory (BDI)
• Coping by Mental Adjustment to Cancer scale (MAC)
• Mood disturbance by Profile of Mood States (POMS)
• QoL by quality of life index
• Coping strategy that was used by Dealing with Illness Inventory
Notes The intervention was carried out in waves as soon as 7 to 10 patients were recruited
Participants were enrolled from time of completion of treatment up to 2 years post-
treatment
89/315 were included, accrual rate (28.2)
Those in whom anxiety and mood disorders were diagnosed were not excluded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Patients were randomised to intervention
and control
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
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Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk “Participants were informed about their as-
signment by mail”
Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk At time 2, assessment data were collected
for 43 (93.5%) in intervention and 34 (79.
1%) in control. At time 3, data collected
for 38 (82.6%) in intervention and 33 for
control (76.7%)
At time 4, data were collected for 30 (65.
2%) in intervention and 25 (58.1%) in
control
Comment: although the numbers of drop-
outs were balanced between the groups, the
percentage of dropouts and subsequent per
protocol analysis posed an unclear risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Other bias Low risk Funded by the Health Services Research
Innovation Fund of the Albert Heritage
Foundation for Medical Research
Comment: this was judged as at a low risk
of bias
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Taylor 2003
Methods Design: RCT
Setting: USA
Duration of intervention: 8 weeks
Participants N = 93 agreed to participate and N = 73 (40 intervention, 33 control) completed the
trial and data were analysed
Inclusion criteria
• African American women with stage 0 to IIIA breast cancer
• Had undergone surgery within the previous 10 months
Exclusion criteria
• Psychotic illness
• Drug or alcohol abuse
• Severe cognitive impairment
• Previous systemic cancer diagnosis
Interventions Intervention n = 40, assessment only control n = 33
Intervention: 8 weekly, 2 hours; 8 members, semi-structured meetings delivered by
psychologist and psychiatrist
Outcomes Assessed at 1 week, 3 months, 6 months and 12 months
Only 12-month outcome reported:
• Cancer-related QoL by CARES-SF
• Mood state by Profile of Mood States (POMS)
• General psychological distress by Mental Health Inventory (MHI)
• Cancer-related distress by Impact of Event Scale
Notes Randomly assigned, 2:1 random assignment:
• “Of 148 eligible women, 62.8% (n = 93) agreed to participate and completed the
baseline interview, 33.1% (n = 49) declined to participate (because they felt burdened
by the illness and treatment, work, or family commitments), and 4% (n = 6) were
unreachable”
• Accrual rate 63%
• The only significant difference between decliners and participants was age
(decliners were older)
• Of the 93 participants, the 3 final participants recruited were not randomised
because of a lack of a complete cohort, and 5 were deceased prior to the 12-month
assessment
• “Of the remaining 85 participants, 1 did not return a complete baseline
questionnaire packet, and at the 12-month follow-up assessment, 8 did not return a
complete questionnaire and 3 declined to participate”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Participants were randomly assigned to ei-
ther the support group intervention or the
assessment-only control condition”
Comment: there was insufficient detail re-
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Taylor 2003 (Continued)
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Accrual rate (63%; 93 out of 148 individ-
uals)
Percentage retained at 12 months was 50%
The overall percentage retained at the 12-
month assessment was 50% (73 out of 148)
“Thus, 73 participants (85.8%) completed
the questionnaire packet at both assess-
ments and are included in these analyses.
There were no demographic ormedical dif-
ferences between those who did and did not
complete the 12-month assessment”
Comment: although the numbers of drop-
outs were balanced between the groups and
the percentage of dropouts was low, subse-
quent per protocol analysis posed an un-
clear risk of bias
Selective reporting (reporting bias) Unclear risk “We focus only on the long-term, 12-
month outcomes, as the results obtained at
the intermediate assessments were virtually
identical”
Comment: this was judged as unclear risk
of bias
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Taylor 2003 (Continued)
Other bias Low risk Nathan Cummings Foundation Grant,
American Cancer Society, National Cancer
InstituteGrant, and theMaryDeWitt Petit
Award (Alumni Association of the Medical
College of Pennsylvania)
Vos 2004
Methods Design: RCT
Setting: Rotterdam, Netherlands
Duration of intervention: 12 weeks
Participants Vos 2004: out of 87 agreed to participate, N = 69 completed study at T2 (34 intervention
versus 35 control)
Vos 2007: out of 87 enrolled, 67 completed trial (33 psychotherapy, 34 support group)
Inclusion criteria
• Had surgery no longer than 4 months ago
• No metastases
• Knows Dutch
• No history of psychiatric illness
• Age between18 and 70 years
Interventions Vos 2004: intervention (group psychotherapy n = 15) versus intervention (group social
support n = 19) versus waiting list (n = 35)
Vos 2007: group psychotherapy (n = 33) versus support group (n = 34)
• Psychotherapy and social intervention were 12-weekly sessions (12 sessions in
total), 2.5 hours each plus 2 additional sessions at 1 and 2 months
• The psychotherapy intervention based on experiential existential premises
enriched with cognitive behavioural component
Outcomes • Emotional Adjustment by Profile of Mood States (POMS)
Vos 2004: outcome measured at T0 within 4 months of surgery before randomisation
and T1 after completion of intervention (baseline and 3 months later)
Vos 2007: at T0, T1 and T3 (taken at 12 months after completion of intervention)
Notes • 87 (34.7%) women enrolled into the study. The reasons for 164 women not
participating were mentioned
• They did not differ on any other demographic, medical, and psychosocial
adjustment variables at baseline
• Participants in intervention did not differ from those in control on any medical or
demographic variable
• Coping excluded as an outcome from our analysis because it was measured only at
T2 and only in the intervention and not in the control group
Risk of bias
Bias Authors’ judgement Support for judgement
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Vos 2004 (Continued)
Random sequence generation (selection
bias)
Unclear risk Participants were randomly allocated to
study arms
Comment: there was insufficient detail re-
ported about the method used to generate
the allocation sequence to allow a clear as-
sessment ofwhether it would produce com-
parable groups
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation
sequence, that is to determine whether in-
tervention allocations could have been fore-
seen in advance of, or during, enrolment,
was not reported
Comment: there was insufficient informa-
tion to permit a clear judgement
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment was not
reported
Comment: there was insufficient informa-
tion to permit a clear judgement of risk of
bias
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Vos 2004: Dropouts 18/87 (20.6%) num-
bers and reasons for dropouts were re-
ported. Women who stopped did not dif-
fer from women who completed on any
medical and demographic variable. How-
ever, they reported less social support than
completers
Vos 2007: Of the 87 women who partic-
ipated in the study, 67 women (77.0%)
completed the study, and 20 dropped out
(23%). Numbers and reasons for not at-
tending were described. With exception of
age, those who dropped out did not dif-
fer on any other demographic, medical,
and psychosocial adjustment variables at
baseline (women who stopped participat-
ing were significantly older). Numbers and
reasons for dropouts were reported
Comment: although the numbers of drop-
outs were balanced between the groups, the
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Vos 2004 (Continued)
percentage of dropouts and subsequent per
protocol analysis posed an unclear risk of
bias
Selective reporting (reporting bias) Low risk The results reported coincide with the out-
comes of interest reported in the trial de-
sign
Coping excluded fromour analysis as it was
measured only at T2 and only in interven-
tion and not in control
Comment: this was judged as at a low risk
of bias
Other bias Low risk Funded by a grant of the Dutch Cancer
Society
Yates 2005
Methods Design: RCT
Setting: Three major metropolitan hospitals, Australia
Duration of intervention: 3 weeks
Participants N = 110 (53 intervention, 57 control) and 1 excluded from analysis for ineligibility
Inclusion criteria
• > 18 years
• Commencing chemotherapy for stage I or II breast cancer
• Women were admitted to the study if they had an Eastern Cooperative Oncology
Group performance rating of one or two
• Haemoglobin level at least 11.6 g/mL at recruitment
Interventions • Intervention: patient received individual fatigue education and support program
delivered on clinic and by phone over 3 (10 to 20) minutes sessions 1 week apart. The
first session was 20 minutes in length and delivered face-to-face. The second and third
sessions were conducted by phone 1 week apart and were 10 minutes in length
• Control: general cancer educational sessions equivalent in number and timing to
sessions provided to intervention. The control sessions were delivered in one face-to-
face session, followed by two phone sessions at 1-week intervals
Outcomes • QoL: European organisation for research- and treatment of cancer QoL
questionnaire C30
• Psychological well being (anxiety and depression): Hospital Anxiety and
Depression scale
• Assessment done at baseline T1, T2, T3, T4
Notes • Because patients receiving chemotherapy face a range of unfamiliar, highly
stressful experiences, especially at their first treatment visit, the first control or
intervention session was conducted at the second treatment visit to minimize the effect
of high initial levels of anxiety on the patient’s ability to participate in the intervention
• Follow-up assessment was conducted on the day of each subsequent treatment
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Yates 2005 (Continued)
cycle to minimize the confounding effects of treatment
• Because there were similar numbers of patients who had received radiotherapy in
both the intervention and control groups, any treatment-related differences between
groups were expected to be similar
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The patient was then randomly as-
signed to intervention or control condi-
tions through a central telephone system
using computer-generated random num-
bers”
Comment: this was judged as at a low risk
of bias
Allocation concealment (selection bias) Unclear risk “Group allocation was concealed from re-
search assistants involved in recruitment
and the baseline and follow-up assess-
ments”
Comment: the method used to conceal the
allocation sequence was not reported to
permit a clear judgment
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants and personnel was
not possible in this type of intervention
Comment: the effect of lack of blinding on
outcome in this type of intervention was
unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “Group allocation was concealed from re-
search assistants involved in recruitment
and the baseline and follow-up assess-
ments”
Comment: the method used to blind the
outcome assessment was not reported to
permit a clear judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only one excluded from analysis due to in-
eligibility
Number of participants who completed
follow-up1 (50 intervention and54 in con-
trol); follow-up 2 (50 intervention and 50
control) and follow-up 3 (49 intervention
and 48 control)
Intention-to-treat analysis was done
Comment: low dropout rates and ITT
analysis suggested a low risk of bias
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Yates 2005 (Continued)
Selective reporting (reporting bias) Unclear risk No data presented for secondary outcomes
(QoL and psychological well-being) be-
cause there was no significant effect of the
intervention for cancer self-efficacy, quality
of life, or psychological well-being
Comment: this was judged as at an unclear
risk of bias
Other bias Low risk “The authors indicated no potential con-
flicts of interest.”
Comment: this was judged as at a low risk
of bias
ABS: Affects Balance Scale
BAI: Beck Anxiety Inventory
BDI: Beck Depression Inventory
BSI: Brief Symptom Inventory
CARES-SF: Cancer Rehabilitation Evaluation System - Short Form
CBI: Cancer Behaviour Inventory
CBT: Cognitive Behavioural Therapy
CED-S: Center for Epidemiological Scale
CNS: Central Nervous System
CSQ: Coping Strategies Questionnaire
FACT: Functional Assessment of Cancer Therapy
IES: Impact of Event Scale
ITT: Intention to Treat
LSSI: Lipp Stress Symptoms Inventory for adults
MAC: Mental Adjustment to Cancer
MATT: Memory and Attention Adaption Training
MHI: Mental Health Inventory
POMS: Profile of Mood States
QoL: Quality of Life
RCT: Randomised Controlled Trial
RE: Relationship Enhancement
RVT: Relaxation and Visualisation Therapy
STAI: State Trait Anxiety Inventory
TAU: Treatment As Usual
Characteristics of excluded studies [ordered by study ID]
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Study Reason for exclusion
Allard 2006 The intervention was merely a means of directing women towards coping strategies that were effective
and not considered a psychological intervention according to our definition
Badger 1999 The intervention was not psychological according to the definition in this review. The outcome
measurement scale was not validated
Badger 2013 Stage IV metastatic disease was included and the intervention was aimed at education and social
support
Bjorneklett 2012 The intervention was not psychological according to the definition in this review
Braden 2000 We could not retrieve information on disease stage
Burton 1991 Not an RCT
Chan 2014 Included all cancer patients and there was no subanalysis for participants with breast cancer
Crane-Okada 2012 The intervention was peer counselling and this does not fit the definition of psychological intervention
in this review
Cruess 2001 Data were a subset of the original article by Antoni 2001
Cunningham 1998 Included women with metastatic breast cancer
David 2011 Included women with metastatic disease
Edelman 1999 Included women with metastatic breast cancer
Freeman 2008 Included women with metastatic breast cancer
Gaston-Johansson 2000 Only women undergoing autologous brain stem transplantation (ABMT) were included
Gil 2005 The outcome was a description of the coping strategy and was not measured by a validated tool
Goodwin 2003 Included women with metastatic breast cancer
Greer 1992 Included participants with any type of cancer
Halkett 2013 The intervention was mainly educational and informative and did not fit the intervention criteria in
this review
Heiney 2003 Not an RCT; only a description of the intervention
Heiney 2012 Outcome was social well-being
Helgeson 2001 The intervention was purely educational
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(Continued)
Hirai 2012 Not an RCT
Hopko 2011 Included women at stage 4 (metastatic) disease
Hosaka 1996 Included women with metastasis
Hoskins 2001 A pilot study and too small to have meaningful statistics and methodology to be adapted
Hsiao 2012 Included women with metastatic disease and the intervention did not fulfil the inclusion criteria in
this review
Klinkhammer-Schalke 2012 The intervention was not psychological according to the definition used in this review
Kwok 2011 The intervention was education and informative, and did not fit the criteria in this review
Lee 2013 The intervention was not psychological and was not led by a professional, mostly dyadic-based edu-
cational and support group
Lengacher 2009 This intervention was not psychological but a form of meditation or yoga - it did not fit our criteria
Leon-Pizarro 2007 Participants included women with breast cancer or gynaecological cancer
Lev 2000 The main problem with this study was that the data were poorly reported so that they could not be
included unless further details were given by the authors. Most of the results were qualitative
Manos 2009 This was not an RCT. The women who agreed to participate were in the intervention group while
those who refused were the control group. Group allocation was based entirely on the patient’s wish
McGregor 2004 This study was designed to test the effects of the Cognitive Behaviour Stress Management (CBSM)
intervention on immune function among a subset of women (N = 29) from the larger trial (Antoni
2001) which was included in this review
McKiernan 2010 A CCT and not an RCT
Naumann 2012 Intervention was mostly supportive and exercise based
Paez 2007 Included women with metastatic and non-metastatic disease
Poorkiani 2010 Intervention was not psychological and instead involved physiotherapy and education
Rosberger 2002 The outcome was coping style as opposed to QoL or psychological morbidity
Rottmann 2012 The intervention was educational and informative and did not fit the criteria in this review
Samarel 1997 The intervention did not fit the eligibility criteria of this review
Samarel 2002 The intervention was mainly social and educational
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(Continued)
Sandgren 2000 The intervention was derived from a psychological intervention that had been shown to be effective,
but it was sufficiently modified in the study that it was no longer deemed as an acceptable psychological
intervention
Sherman 2012 Intervention and outcomes did not fit the definitions and criteria in this review
Shrock 1999 Not an RCT
Sidani 1995 Included women with metastatic and recurrent disease
Thornton 2009 Participants were part of the sample in the parent study (Andersen 2004) which was included in this
review
Walker 1999 The intervention involved self administered tapes
Yan 2001 The outcome did not fit the study criteria
Characteristics of studies awaiting assessment [ordered by study ID]
Gabaldón 1993
Methods RCT
Obstetric department of a public hospital in France
Participants N = 43
Interventions Patients were randomly assigned to a group therapy session which included relaxation treatment or to individual
support therapy
Outcomes Assessed at the moment of surgery for breast cancer, 6 months later (at chemotherapy treatment), and 14 months
after treatment
Physical symptoms, anxiety, positive and negative affect, social support, and coping
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. CBT versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Standardised mean difference in
the change from baseline in
depression
7 637 Std. Mean Difference (IV, Random, 95% CI) -1.01 [-1.83, -0.18]
1.1 Group delivered
intervention (less than 20 hrs)
3 120 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-0.80, 0.14]
1.2 Group delivered
intervention (more than 20
hrs)
1 303 Std. Mean Difference (IV, Random, 95% CI) -0.10 [-0.32, 0.13]
1.3 Group delivered
intervention (less than 20
hrs), study removed due to
heterogeneity
1 70 Std. Mean Difference (IV, Random, 95% CI) -4.43 [-5.32, -3.54]
1.4 Individually delivered
intervention(less than 20 hrs)
2 144 Std. Mean Difference (IV, Random, 95% CI) 1.00 [-3.19, 1.20]
2 Standardised mean difference in
the change from baseline in
depression (excluding Grassen
2013)
6 567 Std. Mean Difference (IV, Random, 95% CI) -0.43 [-0.90, 0.04]
2.1 Group delivered
intervention (less than 20 hrs)
3 120 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-0.80, 0.14]
2.2 Group delivered
intervention (more than 20
hrs)
1 303 Std. Mean Difference (IV, Random, 95% CI) -0.10 [-0.32, 0.13]
2.3 Individually delivered
intervention(less than 20 hrs)
2 144 Std. Mean Difference (IV, Random, 95% CI) 1.00 [-3.19, 1.20]
3 Standardised mean difference in
the change from baseline mean
change in anxiety
8 776 Std. Mean Difference (IV, Random, 95% CI) -0.48 [-0.76, -0.21]
3.1 Group delivered
intervention (less than 20 hrs)
5 358 Std. Mean Difference (IV, Random, 95% CI) -0.44 [-0.85, -0.03]
3.2 Group delivered
intervention (more than 20
hrs)
2 323 Std. Mean Difference (IV, Random, 95% CI) -0.53 [-1.32, 0.26]
3.3 Individually delivered
intervention (less than 20 hrs)
1 95 Std. Mean Difference (IV, Random, 95% CI) -0.78 [-1.20, -0.36]
4 Standardised mean difference in
the change from baseline mood
disturbance
8 1536 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-0.43, -0.13]
4.1 Group delivered
intervention (less than 20 hrs)
6 768 Std. Mean Difference (IV, Random, 95% CI) -0.34 [-0.57, -0.11]
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4.2 Group delivered
intervention (more than 20
hrs)
1 259 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.47, 0.02]
4.3 Individually delivered
intervention (less than 20 hrs)
1 509 Std. Mean Difference (IV, Random, 95% CI) -0.15 [-0.32, 0.03]
5 Standardised mean difference in
quality of life
9 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
5.1 Group delivered
intervention
6 578 Std. Mean Difference (IV, Random, 95% CI) 0.21 [-0.03, 0.46]
5.2 Individually delivered
intervention
3 141 Std. Mean Difference (IV, Random, 95% CI) 0.65 [0.07, 1.23]
6 Standardised mean difference
in the change from baseline
coping
2 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 Group delivered
intervention
1 32 Std. Mean Difference (IV, Random, 95% CI) -0.09 [-0.78, 0.61]
6.2 Individually delivered
intervention
1 36 Std. Mean Difference (IV, Random, 95% CI) -1.28 [-2.01, -0.56]
7 Overall survival (group delivered
intervention)
2 530 Hazard Ratio (Random, 95% CI) 0.76 [0.25, 2.32]
8 Standardised mean difference
in the change from baseline
in depression group delivered
(excluding Grassen 2013)
4 140 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.67, 0.07]
8.1 Group delivered
intervention (less than 20 hrs)
3 120 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-0.80, 0.14]
8.2 Group delivered
intervention (more than 20
hrs)
1 20 Std. Mean Difference (IV, Random, 95% CI) -0.09 [-0.97, 0.79]
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Analysis 1.1. Comparison 1 CBT versus control, Outcome 1 Standardised mean difference in the change
from baseline in depression.
Review: Psychological interventions for women with non-metastatic breast cancer
Comparison: 1 CBT versus control
Outcome: 1 Standardised mean difference in the change from baseline in depression
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Group delivered intervention (less than 20 hrs)
Fukui 2000 25 -1.8 (2.06) 23 -0.7 (1.62) 14.5 % -0.58 [ -1.16, 0.00 ]
Narv ez 2008 19 -3.7 (6.13) 19 -0.43 (6.13) 14.2 % -0.52 [ -1.17, 0.13 ]
Nunes 2007 20 -2.69 (3.83) 14 -3.72 (6.74) 14.1 % 0.19 [ -0.49, 0.88 ]
Subtotal (95% CI) 64 56 42.8 % -0.33 [ -0.80, 0.14 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 3.30, df = 2 (P = 0.19); I2 =39%
Test for overall effect: Z = 1.36 (P = 0.17)
2 Group delivered intervention (more than 20 hrs)
Kissane 2003 154 -0.9 (3.5) 149 -0.6 (2.7) 15.4 % -0.10 [ -0.32, 0.13 ]
Subtotal (95% CI) 154 149 15.4 % -0.10 [ -0.32, 0.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
3 Group delivered intervention (less than 20 hrs), study removed due to heterogeneity
Garssen 2013 34 -44.2 (9.66) 36 -4 (8.26) 13.2 % -4.43 [ -5.32, -3.54 ]
Subtotal (95% CI) 34 36 13.2 % -4.43 [ -5.32, -3.54 ]
Heterogeneity: not applicable
Test for overall effect: Z = 9.77 (P < 0.00001)
4 Individually delivered intervention(less than 20 hrs)
Marchioro 1996 18 -7.17 (4.76) 18 3.94 (5.33) 13.4 % -2.15 [ -2.99, -1.31 ]
Yates 2005 53 0 (2.35) 55 -0.2 (2.06) 15.1 % 0.09 [ -0.29, 0.47 ]
Subtotal (95% CI) 71 73 28.5 % -1.00 [ -3.19, 1.20 ]
Heterogeneity: Tau2 = 2.40; Chi2 = 22.77, df = 1 (P<0.00001); I2 =96%
Test for overall effect: Z = 0.89 (P = 0.37)
Total (95% CI) 323 314 100.0 % -1.01 [ -1.83, -0.18 ]
Heterogeneity: Tau2 = 1.13; Chi2 = 112.04, df = 6 (P<0.00001); I2 =95%
Test for overall effect: Z = 2.40 (P = 0.017)
Test for subgroup differences: Chi2 = 86.20, df = 3 (P = 0.00), I2 =97%
-4 -2 0 2 4
Favours CBT Favours control
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Analysis 1.2. Comparison 1 CBT versus control, Outcome 2 Standardised mean difference in the change
from baseline in depression (excluding Grassen 2013).
Review: Psychological interventions for women with non-metastatic breast cancer
Comparison: 1 CBT versus control
Outcome: 2 Standardised mean difference in the change from baseline in depression (excluding Grassen 2013)
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Group delivered intervention (less than 20 hrs)
Fukui 2000 25 -1.8 (2.06) 23 -0.7 (1.62) 16.5 % -0.58 [ -1.16, 0.00 ]
Narv ez 2008 19 -3.7 (6.13) 19 -0.43 (6.13) 15.5 % -0.52 [ -1.17, 0.13 ]
Nunes 2007 20 -2.69 (3.83) 14 -3.72 (6.74) 15.0 % 0.19 [ -0.49, 0.88 ]
Subtotal (95% CI) 64 56 46.9 % -0.33 [ -0.80, 0.14 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 3.30, df = 2 (P = 0.19); I2 =39%
Test for overall effect: Z = 1.36 (P = 0.17)
2 Group delivered intervention (more than 20 hrs)
Kissane 2003 154 -0.9 (3.5) 149 -0.6 (2.7) 20.9 % -0.10 [ -0.32, 0.13 ]
Subtotal (95% CI) 154 149 20.9 % -0.10 [ -0.32, 0.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
3 Individually delivered intervention(less than 20 hrs)
Marchioro 1996 18 -7.17 (4.76) 18 3.94 (5.33) 12.9 % -2.15 [ -2.99, -1.31 ]
Yates 2005 53 0 (2.35) 55 -0.2 (2.06) 19.3 % 0.09 [ -0.29, 0.47 ]
Subtotal (95% CI) 71 73 32.2 % -1.00 [ -3.19, 1.20 ]
Heterogeneity: Tau2 = 2.40; Chi2 = 22.77, df = 1 (P<0.00001); I2 =96%
Test for overall effect: Z = 0.89 (P = 0.37)
Total (95% CI) 289 278 100.0 % -0.43 [ -0.90, 0.04 ]
Heterogeneity: Tau2 = 0.26; Chi2 = 27.72, df = 5 (P = 0.00004); I2 =82%
Test for overall effect: Z = 1.79 (P = 0.074)
Test for subgroup differences: Chi2 = 1.34, df = 2 (P = 0.51), I2 =0.0%
-4 -2 0 2 4
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Analysis 1.3. Comparison 1 CBT versus control, Outcome 3 Standardised mean difference in the change
from baseline mean change in anxiety.
Review: Psychological interventions for women with non-metastatic breast cancer
Comparison: 1 CBT versus control
Outcome: 3 Standardised mean difference in the change from baseline mean change in anxiety
Study or subgroup Intervention Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Group delivered intervention (less than 20 hrs)
Dolbeault 2009 81 -5.28 (6.48) 87 -2.02 (6.21) 17.3 % -0.51 [ -0.82, -0.20 ]
Fukui 2000 25 -1.07 (2.12) 23 0.7 (3.44) 11.1 % -0.62 [ -1.20, -0.03 ]
Garssen 2013 34 -9.3 (7.74) 36 -11.9 (8.07) 13.4 % 0.32 [ -0.15, 0.80 ]
Narv ez 2008 19 -7.63 (8.53) 19 -0.26 (8.53) 9.6 % -0.85 [ -1.51, -0.18 ]
Nunes 2007 20 -4.69 (5.85) 14 -0.27 (6.16) 9.0 % -0.72 [ -1.43, -0.01 ]
Subtotal (95% CI) 179 179 60.3 % -0.44 [ -0.85, -0.03 ]
Heterogeneity: Tau2 = 0.14; Chi2 = 12.61, df = 4 (P = 0.01); I2 =68%
Test for overall effect: Z = 2.09 (P = 0.036)
2 Group delivered intervention (more than 20 hrs)
Kissane 2003 154 -0.9 (3.4) 149 0 (4.1) 19.2 % -0.24 [ -0.46, -0.01 ]
Loprinzi 2011 12 -16.1 (11.29) 8 -3.8 (10.04) 5.9 % -1.09 [ -2.06, -0.12 ]
Subtotal (95% CI) 166 157 25.1 % -0.53 [ -1.32, 0.26 ]
Heterogeneity: Tau2 = 0.23; Chi2 = 2.79, df = 1 (P = 0.09); I2 =64%
Test for overall effect: Z = 1.31 (P = 0.19)
3 Individually delivered intervention (less than 20 hrs)
Yates 2005 48 -4.7 (2.95) 47 -2.5 (2.65) 14.6 % -0.78 [ -1.20, -0.36 ]
Subtotal (95% CI) 48 47 14.6 % -0.78 [ -1.20, -0.36 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.65 (P = 0.00026)
Total (95% CI) 393 383 100.0 % -0.48 [ -0.76, -0.21 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 19.64, df = 7 (P = 0.01); I2 =64%
Test for overall effect: Z = 3.44 (P = 0.00057)
Test for subgroup differences: Chi2 = 1.31, df = 2 (P = 0.52), I2 =0.0%
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Analysis 1.4. Comparison 1 CBT versus control, Outcome 4 Standardised mean difference in the change
from baseline mood disturbance.
Review: Psychological interventions for women with non-metastatic breast cancer
Comparison: 1 CBT versus control
Outcome: 4 Standardised mean difference in the change from baseline mood disturbance
Study or subgroup Intervention Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Group delivered intervention (less than 20 hrs)
Andersen 2004 114 -12.58 (23.19) 113 -8.11 (19.96) 15.7 % -0.21 [ -0.47, 0.06 ]
Boesen 2011 89 -8.5 (12) 97 -7 (11.5) 14.2 % -0.13 [ -0.42, 0.16 ]
Dolbeault 2009 92 -20.37 (22.07) 96 -6.46 (23.31) 14.0 % -0.61 [ -0.90, -0.32 ]
Fillion 2008 44 -0.68 (2.58) 43 0.43 (3.27) 8.9 % -0.37 [ -0.80, 0.05 ]
Fukui 2000 25 -8.8 (12.76) 23 3.7 (16.46) 5.3 % -0.84 [ -1.43, -0.25 ]
Graves 2003 15 8.33 (25.23) 17 5.14 (24.77) 4.1 % 0.12 [ -0.57, 0.82 ]
Subtotal (95% CI) 379 389 62.2 % -0.34 [ -0.57, -0.11 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 10.81, df = 5 (P = 0.06); I2 =54%
Test for overall effect: Z = 2.93 (P = 0.0033)
2 Group delivered intervention (more than 20 hrs)
Kissane 2003 132 -3.6 (11.3) 127 -1.2 (10.2) 16.6 % -0.22 [ -0.47, 0.02 ]
Subtotal (95% CI) 132 127 16.6 % -0.22 [ -0.47, 0.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.78 (P = 0.075)
3 Individually delivered intervention (less than 20 hrs)
Mishel 2005 244 -0.07 (0.32) 265 -0.02 (0.35) 21.1 % -0.15 [ -0.32, 0.03 ]
Subtotal (95% CI) 244 265 21.1 % -0.15 [ -0.32, 0.03 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.67 (P = 0.094)
Total (95% CI) 755 781 100.0 % -0.28 [ -0.43, -0.13 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 13.21, df = 7 (P = 0.07); I2 =47%
Test for overall effect: Z = 3.58 (P = 0.00034)
Test for subgroup differences: Chi2 = 1.71, df = 2 (P = 0.43), I2 =0.0%
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Analysis 1.5. Comparison 1 CBT versus control, Outcome 5 Standardised mean difference in quality of life.
Review: Psychological interventions for women with non-metastatic breast cancer
Comparison: 1 CBT versus control
Outcome: 5 Standardised mean difference in quality of life
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Group delivered intervention
Boesen 2011 89 8.7 (54) 97 3.7 (56) 24.6 % 0.09 [ -0.20, 0.38 ]
Dolbeault 2009 81 0.35 (0.67) 87 -0.09 (0.67) 23.2 % 0.65 [ 0.34, 0.96 ]
Ferguson 2012 17 0.12 (0.79) 18 -0.02 (5.31) 9.8 % 0.04 [ -0.63, 0.70 ]
Fillion 2008 43 2.33 (5.19) 44 2 (5.8) 17.6 % 0.06 [ -0.36, 0.48 ]
Garssen 2013 34 1.1 (15.04) 36 -1 (15.48) 15.6 % 0.14 [ -0.33, 0.61 ]
Graves 2003 15 -2.7 (11.02) 17 -3.3 (12.95) 9.2 % 0.05 [ -0.65, 0.74 ]
Subtotal (95% CI) 279 299 100.0 % 0.21 [ -0.03, 0.46 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 9.40, df = 5 (P = 0.09); I2 =47%
Test for overall effect: Z = 1.73 (P = 0.083)
2 Individually delivered intervention
Baucom 2009 7 0.74 (0.38) 6 0.03 (0.56) 16.4 % 1.40 [ 0.14, 2.67 ]
Loprinzi 2011 12 6.1 (3.91) 8 6 (3.32) 27.1 % 0.03 [ -0.87, 0.92 ]
Yates 2005 53 3.7 (13.48) 55 -5.8 (12.22) 56.5 % 0.73 [ 0.34, 1.12 ]
Subtotal (95% CI) 72 69 100.0 % 0.65 [ 0.07, 1.23 ]
Heterogeneity: Tau2 = 0.12; Chi2 = 3.38, df = 2 (P = 0.18); I2 =41%
Test for overall effect: Z = 2.20 (P = 0.028)
Test for subgroup differences: Chi2 = 1.87, df = 1 (P = 0.17), I2 =46%
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Analysis 1.6. Comparison 1 CBT versus control, Outcome 6 Standardised mean difference in the change
from baseline coping.
Review: Psychological interventions for women with non-metastatic breast cancer
Comparison: 1 CBT versus control
Outcome: 6 Standardised mean difference in the change from baseline coping
Study or subgroup Intervention Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Group delivered intervention
Graves 2003 15 -3.06 (6.57) 17 -2.49 (6) 100.0 % -0.09 [ -0.78, 0.61 ]
Subtotal (95% CI) 15 17 100.0 % -0.09 [ -0.78, 0.61 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
2 Individually delivered intervention
Marchioro 1996 18 -17.27 (17.36) 18 2.56 (12.48) 100.0 % -1.28 [ -2.01, -0.56 ]
Subtotal (95% CI) 18 18 100.0 % -1.28 [ -2.01, -0.56 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.47 (P = 0.00052)
Test for subgroup differences: Chi2 = 5.43, df = 1 (P = 0.02), I2 =82%
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Analysis 1.7. Comparison 1 CBT versus control, Outcome 7 Overall survival (group delivered intervention).
Review: Psychological interventions for women with non-metastatic breast cancer
Comparison: 1 CBT versus control
Outcome: 7 Overall survival (group delivered intervention)
Study or subgroup Experimental Control log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Andersen 2004 114 113 -0.821 (0.285) 51.8 % 0.44 [ 0.25, 0.77 ]
Kissane 2003 154 149 0.315 (0.356) 48.2 % 1.37 [ 0.68, 2.75 ]
Total (95% CI) 268 262 100.0 % 0.76 [ 0.25, 2.32 ]
Heterogeneity: Tau2 = 0.54; Chi2 = 6.21, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 CBT versus control, Outcome 8 Standardised mean difference in the change
from baseline in depression group delivered (excluding Grassen 2013).
Review: Psychological interventions for women with non-metastatic breast cancer
Comparison: 1 CBT versus control
Outcome: 8 Standardised mean difference in the change from baseline in depression group delivered (excluding Grassen 2013)
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Group delivered intervention (less than 20 hrs)
Fukui 2000 25 -1.8 (2.06) 23 -0.7 (1.62) 32.4 % -0.58 [ -1.16, 0.00 ]
Narv ez 2008 19 -3.7 (6.13) 19 -0.43 (6.13) 27.0 % -0.52 [ -1.17, 0.13 ]
Nunes 2007 20 -2.69 (3.83) 14 -3.72 (6.74) 24.6 % 0.19 [ -0.49, 0.88 ]
Subtotal (95% CI) 64 56 84.0 % -0.33 [ -0.80, 0.14 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 3.30, df = 2 (P = 0.19); I2 =39%
Test for overall effect: Z = 1.36 (P = 0.17)
2 Group delivered intervention (more than 20 hrs)
Kissane 2003 10 -0.9 (3.5) 10 -0.6 (2.7) 16.0 % -0.09 [ -0.97, 0.79 ]
Subtotal (95% CI) 10 10 16.0 % -0.09 [ -0.97, 0.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.84)
Total (95% CI) 74 66 100.0 % -0.30 [ -0.67, 0.07 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 3.56, df = 3 (P = 0.31); I2 =16%
Test for overall effect: Z = 1.57 (P = 0.12)
Test for subgroup differences: Chi2 = 0.21, df = 1 (P = 0.64), I2 =0.0%
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A P P E N D I C E S
Appendix 1. CENTRAL
#1 MeSH descriptor: [Breast Neoplasms] explode all trees
#2 (metastatic or advanced) and (breast cancer or breast neoplasm or breast carcinoma or breast tumour or breast tumor)
#3 #1 not #2
#4 MeSH descriptor: [Psychotherapy] explode all trees
#5 MeSH descriptor: [Psychotherapy, Group] explode all trees
#6 MeSH descriptor: [Social Support] explode all trees
#7 MeSH descriptor: [Cognitive Therapy] explode all trees
#8 MeSH descriptor: [Behavior Therapy] explode all trees
#9 MeSH descriptor: [Cognitive Therapy] explode all trees
#10 MeSH descriptor: [Counseling] explode all trees
#11 psychotherapeutic or CBT or acceptance and commitment therapy or psycho-educational intervention
#12 #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11
#13 #3 and #12
Appendix 2. MEDLINE
# Searches
1 randomised controlled trial.pt.
2 randomized controlled trial.pt.
3 controlled clinical trial.pt.
4 randomized.ab.
5 randomised.ab.
6 placebo.ab.
7 randomly.ab.
8 trial.ab.
9 groups.ab.
10 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9
11 exp Breast Neoplasms/
12 breast cancer.mp.
13 breast carcinoma.mp.
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(Continued)
14 breast tumour.mp.
15 breast tumor.mp.
16 breast neoplasm.mp.
17 11 or 12 or 13 or 14 or 15 or 16
18 exp Psychotherapy/
19 Psychotherapy, Group/
20 exp Social Support/
21 exp Cognitive Therapy/
22 exp Behavior Therapy/
23 exp Counseling/
24 cognitive behavio?ral therapy.mp.
25 cognitive behavio?ral technique.mp.
26 psychotherapeutic.mp.
27 CBT.mp.
28 (acceptance and commitment therapy).mp. [mp=title, abstract, original title, name of substance word, subject heading word,
keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier]
29 psycho-educational intervention.mp.
30 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29
31 10 and 17 and 30
32 Animals/
33 Humans/
34 32 not 33
35 31 not 34
36 limit 35 to yr=“2008 -Current”
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Appendix 3. EMBASE
1. random* OR factorial* OR crossover* OR cross AND over* OR placebo* OR (doubl* AND blind*) OR (singl* AND blind*)
OR assign* OR allocat* OR volunteer* OR ’crossover
2. ’breast neoplasm’
3. ’breast cancer’/exp OR ’breast cancer’
4. ’breast carcinoma’/exp OR ’breast carcinoma’
5. ’breast tumour’
6. ’breast tumor’/exp OR ’breast tumor’
7. #2 OR #3 OR #4 OR #5 OR #6
8. ’psychotherapy’/exp OR psychotherapy
9. ’group psychotherapy’/exp OR ’group psychotherapy’
10. ’social support’/exp OR ’social support’
11. ’cognitive behavioural therapy’/exp OR ’cognitive behavioural therapy’
12. ’cognitive behavioral therapy’/exp OR ’cognitive behavioral therapy’
13. ’counseling’/exp OR counseling
14. psychotherapeutic
15. cbt
16. ’psycho-educational intervention’
17. ’acceptance and commitment therapy’
18. #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17
19. #1 AND #7 AND #18
20. #19 AND [humans]/lim AND [embase]/lim AND [2008-2013]/py
Appendix 4. PsycINFO
# Searches
1 exp Clinical Trials/ or randomised controlled trial.mp.
2 randomized controlled trial.mp. or exp Clinical Trials/
3 exp Clinical Trials/ or controlled clinical trial.mp.
4 randomized.ab.
5 randomised.ab.
6 placebo.ab.
7 randomly.ab.
8 trial.ab.
9 groups.ab.
10 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9
11 exp Breast Neoplasms/
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(Continued)
12 breast cancer.mp.
13 breast neoplasm.mp.
14 breast carcinoma.mp.
15 breast tumo?r.mp.
16 11 or 12 or 13 or 14 or 15
17 exp Psychotherapy/
18 exp Group Psychotherapy/
19 exp Social Support/
20 exp Cognitive Behavior Therapy/
21 exp Cognitive Therapy/
22 exp Counseling/
23 exp Psychotherapeutic Techniques/
24 psychotherapeutic.mp.
25 CBT.mp.
26 (acceptance and commitment therapy).mp. [mp=title, abstract, heading word, table of contents, key concepts, original title,
tests & measures]
27 exp Psychoeducation/
28 psycho-educational intervention.mp.
29 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28
30 10 and 16 and 29
31 limit 30 to human
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Appendix 5. CINAHL
Search ID# Search Terms Search Options
S24 S8 and S15 and S23 Limiters - Exclude MEDLINE records; Human
Search modes - Boolean/Phrase
S23 S16 or S17 or S18 or S19 or S20 or S21 or S22 Search modes - Boolean/Phrase
S22 (MH “Counseling+”) OR counsel#ing Search modes - Boolean/Phrase
S21 social AND support Search modes - Boolean/Phrase
S20 cognitive behavio#r* technique* Search modes - Boolean/Phrase
S19 (MH “Behavior Therapy+”) OR behavio#r* therap* Search modes - Boolean/Phrase
S18 psychological intervention* OR (MH “Psychology, Edu-
cational+”) OR (MH “Psychology, Clinical”) OR (MH
“Psychology, Applied+”) OR (MH “Psychological Well-
Being”)OR (MH“Psychology, Social+”)OR (MH“Stress,
Psychological+”)OR (MH“Psychology+”)OR (MH“Psy-
chological Techniques+”)
Search modes - Boolean/Phrase
S17 (MH “Psychosocial Care (Saba CCC)+”) OR (MH“Reha-
bilitation, Psychosocial+”) OR (MH “Support, Psychoso-
cial+”) OR psychosocial intervention*
Search modes - Boolean/Phrase
S16 (MH “Psychotherapy+”) OR psychotherapy OR (MH
“Psychotherapy, Brief ”) OR (MH “Psychotherapy,
Group+”) OR (MH “Cognitive Therapy”)
Search modes - Boolean/Phrase
S15 S9 NOT S14 Search modes - Boolean/Phrase
S14 S10 or S11 or S12 or S13 Search modes - Boolean/Phrase
S13 metastatic breast neoplas* Search modes - Boolean/Phrase
S12 metastatic breast tumo#r* Search modes - Boolean/Phrase
S11 metastatic breast carcinoma* Search modes - Boolean/Phrase
S10 metastatic breast cancer* Search modes - Boolean/Phrase
S9 (MH “Breast Neoplasms+”) OR (MH “Carcinoma, Duc-
tal, Breast”) OR breast cancer*
Search modes - Boolean/Phrase
S8 S1 or S2 or S3 or S4 or S5 or S6 or S7 Search modes - Boolean/Phrase
S7 AB groups Search modes - Boolean/Phrase
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(Continued)
S6 AB trial Search modes - Boolean/Phrase
S5 AB randomly Search modes - Boolean/Phrase
S4 AB placebo Search modes - Boolean/Phrase
S3 AB randomi* Search modes - Boolean/Phrase
S2 (MH “Clinical Trials+”) OR (MH “Clinical Trial Reg-
istry”) OR (MH “Cochrane Library”) OR controlled clin-
ical trial OR (MH “Preventive Trials”) OR (MH “Com-
munity Trials”) OR (MH “Intervention Trials”) OR (MH
“Nonrandomized Trials”) OR (MH “Therapeutic Trials”)
OR (MH “Case Control Studies+”)
Search modes - Boolean/Phrase
S1 (MH “Clinical Trials+”) OR (MH “Cochrane Library”)
OR (MH “Preventive Trials”) OR (MH “Community Tri-
als”) OR (MH “Intervention Trials”) OR (MH “Nonran-
domized Trials”) OR (MH “Therapeutic Trials”) OR (MH
“Case Control Studies+”) OR randomi?ed controlled trial
OR (MH “Clinical Trial Registry”)
Search modes - Boolean/Phrase
Appendix 6. WHO ICTRP
Basic Searches:
1. breast cancer* NOT metastatic AND psychosocial intervention*
2. breast cancer* NOT advance* AND psychosocial intervention*
3. breast cancer* NOT metastatic AND cognitive behavioural technique*
4. breast cancer* NOT advance* AND cognitive behavioural technique*
5. breast cancer* NOT metastatic AND cognitive behavioral technique*
6. breast cancer* NOT advance* AND cognitive behavioral technique*
7. breast cancer* NOT metastatic AND psychotherap*
8. breast cancer* NOT advance* AND psychotherap*
9. breast cancer* NOT metastatic AND psycho-education* intervention*
10. breast cancer* NOT advance* AND psycho-education*intervention*
11. breast cancer* NOT metastatic AND counselling
12. breast cancer* NOT advance* AND counselling
Advanced Searches:
1. Title: psychological intervention* for women with non-metastatic breast cancer
Recruitment status: ALL
2. Condition: breast cancer* NOT (metastatic OR advance*)
Intervention: psychosocial intervention*
Recruitment status: ALL
3. Condition: breast cancer* NOT (metastatic OR advance*)
Intervention: cognitive behavioural technique*
Recruitment status: ALL
4. Condition: breast cancer* NOT (metastatic OR advance*)
Intervention: cognitive behavioral technique*
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Recruitment status: ALL
5. Condition: breast cancer* NOT (metastatic OR advance*)
Intervention: behavioral technique*
Recruitment status: ALL
6. Condition: breast cancer* NOT (metastatic OR advance*)
Intervention: psychotherap*
Recruitment status: ALL
7. Condition: breast cancer* NOT (metastatic OR advance*)
Intervention: psycho-education intervention*
Recruitment status: ALL
8. Condition: breast cancer* NOT (metastatic OR advance*)
Intervention: counselling
Recruitment status: ALL
Appendix 7. ClinicalTrials.gov
Basic Searches:
1. breast cancer* NOT (metastastic OR advance*) AND (psychosocial intervention* OR cognitive behavioural technique*OR cognitive
behavioral technique* OR psychotherap* OR psycho-education* intervention* OR counselling)
2. breast cancer* NOT (metastastic OR advance*) AND (cognitive behavioral therapy OR cognitive behavioural therapy)
Advanced Searches:
1. Title: psychological intervention* for women with non-metastatic breast cancer
Recruitment status: All studies
Recruitment: All studies
Study results: All studies
Study type: All studies
2. Condition: breast cancer* NOT (metastastic OR advance*)
Intervention: psychosocial intervention* OR cognitive behavioural technique*OR cognitive behavioral technique* OR psychotherap*
OR psycho-education* intervention* OR counselling
Recruitment status: All studies
Recruitment: All studies
Study results: All studies
Study type: All studies
3. Condition: breast cancer* NOT (metastastic OR advance*)
Intervention: cognitive behavioral therapy OR cognitive behavioural therapy
Recruitment status: All studies
Recruitment: All studies
Study results: All studies
Study type: All studies
Appendix 8. CancerLit
1. breast cancer* NOT (metastastic OR advance*) AND (psychosocial intervention* OR cognitive behavioural technique*OR cognitive
behavioral technique* OR psychotherap* OR psycho-education* intervention* OR counselling)
2. breast cancer* NOT (metastastic OR advance*) AND (cognitive behavioral therapy OR cognitive behavioural therapy)
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Appendix 9. PsycLit
1. breast cancer* NOT (metastastic OR advance*) AND (psychosocial intervention* OR cognitive behavioural technique*OR cognitive
behavioral technique* OR psychotherap* OR psycho-education* intervention* OR counselling)
2. breast cancer* NOT (metastastic OR advance*) AND (cognitive behavioral therapy OR cognitive behavioural therapy)
Appendix 10. Iranmedex
1. breast cancer* NOT (metastastic OR advance*) AND (psychosocial intervention* OR cognitive behavioural technique*OR cognitive
behavioral technique* OR psychotherap* OR psycho-education* intervention* OR counselling)
2. breast cancer* NOT (metastastic OR advance*) AND (cognitive behavioral therapy OR cognitive behavioural therapy)
Appendix 11. IndMed
1. breast cancer* NOT (metastastic OR advance*) AND (psychosocial intervention* OR cognitive behavioural technique*OR cognitive
behavioral technique* OR psychotherap* OR psycho-education* intervention* OR counselling)
2. breast cancer* NOT (metastastic OR advance*) AND (cognitive behavioral therapy OR cognitive behavioural therapy)
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• Nil, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Mood disturbance was not determined a priori in the protocol but was added to the review because it was used interchangeably with
depression in many studies.
The published protocol stated that the primary outcomes would be (and in this order): QoL, depression and anxiety, stress, distress,
coping and adjustment, overall survival and adverse events. However, in the review, and based on the reviewer’s comments and in light
of the Cochrane Handbook for Systematic Reviews of Interventions, a preferable alternative order has been used that divides the outcomes
into primary (which are themain psychological outcomes of interest and the sole purpose of this review in the order: depression, anxiety,
stress, mood disturbance) and secondary outcomes (which are complementary but not essential: quality of life, coping, adjustment,
and survival). The new order of outcomes gives more structure to the description of outcomes and focus on the main objective of this
review, which is assessing the main and most prevalent psychological morbidities as primary outcomes.
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